CN103436537B - Lily ester floral gene LoAAT1 and application thereof - Google Patents
Lily ester floral gene LoAAT1 and application thereof Download PDFInfo
- Publication number
- CN103436537B CN103436537B CN201310369037.7A CN201310369037A CN103436537B CN 103436537 B CN103436537 B CN 103436537B CN 201310369037 A CN201310369037 A CN 201310369037A CN 103436537 B CN103436537 B CN 103436537B
- Authority
- CN
- China
- Prior art keywords
- gene
- lily
- loaat1
- ester
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 118
- 241000234435 Lilium Species 0.000 title claims abstract description 63
- 150000002148 esters Chemical class 0.000 title claims abstract description 34
- 239000003205 fragrance Substances 0.000 claims abstract description 45
- 241000196324 Embryophyta Species 0.000 claims abstract description 38
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 19
- 239000013598 vector Substances 0.000 claims abstract description 19
- 230000009261 transgenic effect Effects 0.000 claims abstract description 12
- 230000009466 transformation Effects 0.000 claims abstract description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 239000002299 complementary DNA Substances 0.000 claims description 31
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
- 238000010367 cloning Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000008676 import Effects 0.000 claims 1
- 230000014509 gene expression Effects 0.000 abstract description 21
- 238000000034 method Methods 0.000 abstract description 15
- 238000009395 breeding Methods 0.000 abstract description 7
- 230000001488 breeding effect Effects 0.000 abstract description 7
- 239000003147 molecular marker Substances 0.000 abstract description 4
- 239000002773 nucleotide Substances 0.000 abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000009394 selective breeding Methods 0.000 abstract 1
- 239000013615 primer Substances 0.000 description 39
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 34
- 108020004414 DNA Proteins 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 239000012634 fragment Substances 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 21
- 108010083294 ethanol acyltransferase Proteins 0.000 description 17
- 239000013612 plasmid Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 244000061176 Nicotiana tabacum Species 0.000 description 14
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 238000012546 transfer Methods 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- 108700016155 Acyl transferases Proteins 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 235000013399 edible fruits Nutrition 0.000 description 10
- 102000057234 Acyl transferases Human genes 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 238000003753 real-time PCR Methods 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 7
- -1 phenylpropanoic acid compounds Chemical class 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 108091060211 Expressed sequence tag Proteins 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- VEVJTUNLALKRNO-TYHXJLICSA-N benzoyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C1=CC=CC=C1 VEVJTUNLALKRNO-TYHXJLICSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 238000001976 enzyme digestion Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 235000016623 Fragaria vesca Nutrition 0.000 description 5
- 240000009088 Fragaria x ananassa Species 0.000 description 5
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 5
- 239000011543 agarose gel Substances 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000009465 prokaryotic expression Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 108700014220 acyltransferase activity proteins Proteins 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 4
- 235000019445 benzyl alcohol Nutrition 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- RGXWDWUGBIJHDO-UHFFFAOYSA-N ethyl decanoate Chemical compound CCCCCCCCCC(=O)OCC RGXWDWUGBIJHDO-UHFFFAOYSA-N 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- 244000241257 Cucumis melo Species 0.000 description 3
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- 240000007377 Petunia x hybrida Species 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- 108060000712 Benzoate-CoA ligase Proteins 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- 241000219930 Clarkia Species 0.000 description 2
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 241000219828 Medicago truncatula Species 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000519995 Stachys sylvatica Species 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 229940007550 benzyl acetate Drugs 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 230000008124 floral development Effects 0.000 description 2
- 230000004345 fruit ripening Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- OSORMYZMWHVFOZ-UHFFFAOYSA-N phenethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCC1=CC=CC=C1 OSORMYZMWHVFOZ-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 2
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- CWFMWBHMIMNZLN-NAKRPEOUSA-N (2s)-1-[(2s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CWFMWBHMIMNZLN-NAKRPEOUSA-N 0.000 description 1
- FMYBFLOWKQRBST-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]acetic acid;nickel Chemical compound [Ni].OC(=O)CN(CC(O)=O)CC(O)=O FMYBFLOWKQRBST-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 1
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 1
- KVWLTGNCJYDJET-LSJOCFKGSA-N Ala-Arg-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KVWLTGNCJYDJET-LSJOCFKGSA-N 0.000 description 1
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 1
- JMCUQXTXLJEQSY-XKNYDFJKSA-N Ala-Asn-Asn-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O JMCUQXTXLJEQSY-XKNYDFJKSA-N 0.000 description 1
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 1
- JPGBXANAQYHTLA-DRZSPHRISA-N Ala-Gln-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JPGBXANAQYHTLA-DRZSPHRISA-N 0.000 description 1
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 1
- WOPFJPHVBWKZJH-SRVKXCTJSA-N Arg-Arg-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O WOPFJPHVBWKZJH-SRVKXCTJSA-N 0.000 description 1
- PBSOQGZLPFVXPU-YUMQZZPRSA-N Arg-Glu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PBSOQGZLPFVXPU-YUMQZZPRSA-N 0.000 description 1
- OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 1
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 1
- UHFUZWSZQKMDSX-DCAQKATOSA-N Arg-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UHFUZWSZQKMDSX-DCAQKATOSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 1
- VEAIMHJZTIDCIH-KKUMJFAQSA-N Arg-Phe-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O VEAIMHJZTIDCIH-KKUMJFAQSA-N 0.000 description 1
- STHNZYKCJHWULY-AVGNSLFASA-N Arg-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O STHNZYKCJHWULY-AVGNSLFASA-N 0.000 description 1
- JPAWCMXVNZPJLO-IHRRRGAJSA-N Arg-Ser-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JPAWCMXVNZPJLO-IHRRRGAJSA-N 0.000 description 1
- XHFXZQHTLJVZBN-FXQIFTODSA-N Asn-Arg-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N XHFXZQHTLJVZBN-FXQIFTODSA-N 0.000 description 1
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 1
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 1
- CJUKAWUWBZCTDQ-SRVKXCTJSA-N Asp-Leu-Lys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O CJUKAWUWBZCTDQ-SRVKXCTJSA-N 0.000 description 1
- KFAFUJMGHVVYRC-DCAQKATOSA-N Asp-Leu-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O KFAFUJMGHVVYRC-DCAQKATOSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 101100380241 Caenorhabditis elegans arx-2 gene Proteins 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001508790 Clarkia breweri Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000555675 Gentiana triflora Species 0.000 description 1
- KCJJFESQRXGTGC-BQBZGAKWSA-N Gln-Glu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O KCJJFESQRXGTGC-BQBZGAKWSA-N 0.000 description 1
- QBEWLBKBGXVVPD-RYUDHWBXSA-N Gln-Phe-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N QBEWLBKBGXVVPD-RYUDHWBXSA-N 0.000 description 1
- HMIXCETWRYDVMO-GUBZILKMSA-N Gln-Pro-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O HMIXCETWRYDVMO-GUBZILKMSA-N 0.000 description 1
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 1
- NYCVMJGIJYQWDO-CIUDSAMLSA-N Gln-Ser-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NYCVMJGIJYQWDO-CIUDSAMLSA-N 0.000 description 1
- VDMABHYXBULDGN-LAEOZQHASA-N Gln-Val-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O VDMABHYXBULDGN-LAEOZQHASA-N 0.000 description 1
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 1
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 1
- MLILEEIVMRUYBX-NHCYSSNCSA-N Glu-Val-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O MLILEEIVMRUYBX-NHCYSSNCSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 1
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 1
- UEGIPZAXNBYCCP-NKWVEPMBSA-N Gly-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)CN)C(=O)O UEGIPZAXNBYCCP-NKWVEPMBSA-N 0.000 description 1
- FIQQRCFQXGLOSZ-WDSKDSINSA-N Gly-Glu-Asp Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FIQQRCFQXGLOSZ-WDSKDSINSA-N 0.000 description 1
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 description 1
- YYPFZVIXAVDHIK-IUCAKERBSA-N Gly-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN YYPFZVIXAVDHIK-IUCAKERBSA-N 0.000 description 1
- KAJAOGBVWCYGHZ-JTQLQIEISA-N Gly-Gly-Phe Chemical compound [NH3+]CC(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KAJAOGBVWCYGHZ-JTQLQIEISA-N 0.000 description 1
- UESJMAMHDLEHGM-NHCYSSNCSA-N Gly-Ile-Leu Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O UESJMAMHDLEHGM-NHCYSSNCSA-N 0.000 description 1
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 1
- PYFIQROSWQERAS-LBPRGKRZSA-N Gly-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(=O)NCC(O)=O)=CNC2=C1 PYFIQROSWQERAS-LBPRGKRZSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- YPLYIXGKCRQZGW-SRVKXCTJSA-N His-Arg-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YPLYIXGKCRQZGW-SRVKXCTJSA-N 0.000 description 1
- XVZJRZQIHJMUBG-TUBUOCAGSA-N His-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CN=CN1)N XVZJRZQIHJMUBG-TUBUOCAGSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- HDOYNXLPTRQLAD-JBDRJPRFSA-N Ile-Ala-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)N HDOYNXLPTRQLAD-JBDRJPRFSA-N 0.000 description 1
- QLRMMMQNCWBNPQ-QXEWZRGKSA-N Ile-Arg-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)N QLRMMMQNCWBNPQ-QXEWZRGKSA-N 0.000 description 1
- HVWXAQVMRBKKFE-UGYAYLCHSA-N Ile-Asp-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HVWXAQVMRBKKFE-UGYAYLCHSA-N 0.000 description 1
- BALLIXFZYSECCF-QEWYBTABSA-N Ile-Gln-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N BALLIXFZYSECCF-QEWYBTABSA-N 0.000 description 1
- WZDCVAWMBUNDDY-KBIXCLLPSA-N Ile-Glu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)N WZDCVAWMBUNDDY-KBIXCLLPSA-N 0.000 description 1
- AFERFBZLVUFWRA-HTFCKZLJSA-N Ile-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)O)N AFERFBZLVUFWRA-HTFCKZLJSA-N 0.000 description 1
- HQEPKOFULQTSFV-JURCDPSOSA-N Ile-Phe-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)O)N HQEPKOFULQTSFV-JURCDPSOSA-N 0.000 description 1
- OWSWUWDMSNXTNE-GMOBBJLQSA-N Ile-Pro-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N OWSWUWDMSNXTNE-GMOBBJLQSA-N 0.000 description 1
- KCTIFOCXAIUQQK-QXEWZRGKSA-N Ile-Pro-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O KCTIFOCXAIUQQK-QXEWZRGKSA-N 0.000 description 1
- MLSUZXHSNRBDCI-CYDGBPFRSA-N Ile-Pro-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)O)N MLSUZXHSNRBDCI-CYDGBPFRSA-N 0.000 description 1
- YHFPHRUWZMEOIX-CYDGBPFRSA-N Ile-Val-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)N YHFPHRUWZMEOIX-CYDGBPFRSA-N 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- UCOCBWDBHCUPQP-DCAQKATOSA-N Leu-Arg-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O UCOCBWDBHCUPQP-DCAQKATOSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 1
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 1
- UCDHVOALNXENLC-KBPBESRZSA-N Leu-Gly-Tyr Chemical compound CC(C)C[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 UCDHVOALNXENLC-KBPBESRZSA-N 0.000 description 1
- AUBMZAMQCOYSIC-MNXVOIDGSA-N Leu-Ile-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O AUBMZAMQCOYSIC-MNXVOIDGSA-N 0.000 description 1
- OMHLATXVNQSALM-FQUUOJAGSA-N Leu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(C)C)N OMHLATXVNQSALM-FQUUOJAGSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N Leu-Phe-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 1
- SVJRVFPSHPGWFF-DCAQKATOSA-N Lys-Cys-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVJRVFPSHPGWFF-DCAQKATOSA-N 0.000 description 1
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 101000964239 Malus domestica Alcohol acyl transferase 2 Proteins 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 1
- VEKRTVRZDMUOQN-AVGNSLFASA-N Met-Val-His Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 VEKRTVRZDMUOQN-AVGNSLFASA-N 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 101100476480 Mus musculus S100a8 gene Proteins 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 101100165269 Petunia hybrida BEBT1 gene Proteins 0.000 description 1
- VHWOBXIWBDWZHK-IHRRRGAJSA-N Phe-Arg-Asp Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 VHWOBXIWBDWZHK-IHRRRGAJSA-N 0.000 description 1
- WGXOKDLDIWSOCV-MELADBBJSA-N Phe-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O WGXOKDLDIWSOCV-MELADBBJSA-N 0.000 description 1
- MGECUMGTSHYHEJ-QEWYBTABSA-N Phe-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGECUMGTSHYHEJ-QEWYBTABSA-N 0.000 description 1
- IWZRODDWOSIXPZ-IRXDYDNUSA-N Phe-Phe-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C1=CC=CC=C1 IWZRODDWOSIXPZ-IRXDYDNUSA-N 0.000 description 1
- GRVMHFCZUIYNKQ-UFYCRDLUSA-N Phe-Phe-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GRVMHFCZUIYNKQ-UFYCRDLUSA-N 0.000 description 1
- YVXPUUOTMVBKDO-IHRRRGAJSA-N Phe-Pro-Cys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CS)C(=O)O YVXPUUOTMVBKDO-IHRRRGAJSA-N 0.000 description 1
- MVIJMIZJPHQGEN-IHRRRGAJSA-N Phe-Ser-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@H](CO)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 MVIJMIZJPHQGEN-IHRRRGAJSA-N 0.000 description 1
- GMWNQSGWWGKTSF-LFSVMHDDSA-N Phe-Thr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMWNQSGWWGKTSF-LFSVMHDDSA-N 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- DRVIASBABBMZTF-GUBZILKMSA-N Pro-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@@H]1CCCN1 DRVIASBABBMZTF-GUBZILKMSA-N 0.000 description 1
- JUJGNDZIKKQMDJ-IHRRRGAJSA-N Pro-His-His Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O JUJGNDZIKKQMDJ-IHRRRGAJSA-N 0.000 description 1
- MCWHYUWXVNRXFV-RWMBFGLXSA-N Pro-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 MCWHYUWXVNRXFV-RWMBFGLXSA-N 0.000 description 1
- SWRNSCMUXRLHCR-ULQDDVLXSA-N Pro-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 SWRNSCMUXRLHCR-ULQDDVLXSA-N 0.000 description 1
- HWLKHNDRXWTFTN-GUBZILKMSA-N Pro-Pro-Cys Chemical compound C1C[C@H](NC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CS)C(=O)O HWLKHNDRXWTFTN-GUBZILKMSA-N 0.000 description 1
- CXGLFEOYCJFKPR-RCWTZXSCSA-N Pro-Thr-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O CXGLFEOYCJFKPR-RCWTZXSCSA-N 0.000 description 1
- FZXSYIPVAFVYBH-KKUMJFAQSA-N Pro-Tyr-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O FZXSYIPVAFVYBH-KKUMJFAQSA-N 0.000 description 1
- STGVYUTZKGPRCI-GUBZILKMSA-N Pro-Val-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 STGVYUTZKGPRCI-GUBZILKMSA-N 0.000 description 1
- MTMJNKFZDQEVSY-BZSNNMDCSA-N Pro-Val-Trp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O MTMJNKFZDQEVSY-BZSNNMDCSA-N 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 108010079005 RDV peptide Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- KNZQGAUEYZJUSQ-ZLUOBGJFSA-N Ser-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N KNZQGAUEYZJUSQ-ZLUOBGJFSA-N 0.000 description 1
- GRSLLFZTTLBOQX-CIUDSAMLSA-N Ser-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N GRSLLFZTTLBOQX-CIUDSAMLSA-N 0.000 description 1
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 1
- GVIGVIOEYBOTCB-XIRDDKMYSA-N Ser-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC(C)C)C(O)=O)=CNC2=C1 GVIGVIOEYBOTCB-XIRDDKMYSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000583907 Taraka Species 0.000 description 1
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 1
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 1
- JQAWYCUUFIMTHE-WLTAIBSBSA-N Thr-Gly-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JQAWYCUUFIMTHE-WLTAIBSBSA-N 0.000 description 1
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 1
- DXPURPNJDFCKKO-RHYQMDGZSA-N Thr-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DXPURPNJDFCKKO-RHYQMDGZSA-N 0.000 description 1
- WVVOFCVMHAXGLE-LFSVMHDDSA-N Thr-Phe-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O WVVOFCVMHAXGLE-LFSVMHDDSA-N 0.000 description 1
- JAJOFWABAUKAEJ-QTKMDUPCSA-N Thr-Pro-His Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O JAJOFWABAUKAEJ-QTKMDUPCSA-N 0.000 description 1
- UABYBEBXFFNCIR-YDHLFZDLSA-N Tyr-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UABYBEBXFFNCIR-YDHLFZDLSA-N 0.000 description 1
- CDKZJGMPZHPAJC-ULQDDVLXSA-N Tyr-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDKZJGMPZHPAJC-ULQDDVLXSA-N 0.000 description 1
- NKMFRGPKTIEXSK-ULQDDVLXSA-N Tyr-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NKMFRGPKTIEXSK-ULQDDVLXSA-N 0.000 description 1
- DNOOLPROHJWCSQ-RCWTZXSCSA-N Val-Arg-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DNOOLPROHJWCSQ-RCWTZXSCSA-N 0.000 description 1
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 1
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 1
- JXGWQYWDUOWQHA-DZKIICNBSA-N Val-Gln-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N JXGWQYWDUOWQHA-DZKIICNBSA-N 0.000 description 1
- AHHJARQXFFGOKF-NRPADANISA-N Val-Glu-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N AHHJARQXFFGOKF-NRPADANISA-N 0.000 description 1
- VVZDBPBZHLQPPB-XVKPBYJWSA-N Val-Glu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VVZDBPBZHLQPPB-XVKPBYJWSA-N 0.000 description 1
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- MNSSBIHFEUUXNW-RCWTZXSCSA-N Val-Thr-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N MNSSBIHFEUUXNW-RCWTZXSCSA-N 0.000 description 1
- GUIYPEKUEMQBIK-JSGCOSHPSA-N Val-Tyr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(O)=O GUIYPEKUEMQBIK-JSGCOSHPSA-N 0.000 description 1
- XNLUVJPMPAZHCY-JYJNAYRXSA-N Val-Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 XNLUVJPMPAZHCY-JYJNAYRXSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 101150092805 actc1 gene Proteins 0.000 description 1
- 108010069175 acyl-CoA transferase Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- QUMXDOLUJCHOAY-UHFFFAOYSA-N alpha-methylbenzyl acetate Natural products CC(=O)OC(C)C1=CC=CC=C1 QUMXDOLUJCHOAY-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940059756 arava Drugs 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 108010003103 benzyl alcohol acetyltransferase Proteins 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- ODLMAHJVESYWTB-UHFFFAOYSA-N ethylmethylbenzene Natural products CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 238000001319 headspace solid-phase micro-extraction Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940098888 phenethyl benzoate Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 108010065135 phenylalanyl-phenylalanyl-phenylalanine Proteins 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000002470 solid-phase micro-extraction Methods 0.000 description 1
- 108010087432 terpene synthase Proteins 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 108010003137 tyrosyltyrosine Proteins 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
技术领域 technical field
本发明涉及基因工程技术领域,具体地,涉及一种百合酯类花香基因LoAAT1及其应用。 The invention relates to the technical field of genetic engineering, in particular to a lily ester floral fragrance gene LoAAT1 and its application.
背景技术 Background technique
大多数植物的花香是由一系列低分子量的挥发物混合在一起形成,其化学成分主要是萜烯类化合物、苯丙酸类化合物/苯环型化合物和脂肪酸衍生物(Pichersky et al,2006;Dudareva et al,2004)。经莽草酸途径形成的苯丙烷类酯类成分苯甲酸乙酯是百合主要特征香气成分之一(范燕萍,2008)。 The floral fragrance of most plants is formed by a series of low-molecular-weight volatiles mixed together, and its chemical components are mainly terpenes, phenylpropanoic acid compounds/benzene ring compounds and fatty acid derivatives (Pichersky et al , 2006; Dudareva et al , 2004). Ethyl benzoate, a phenylpropane ester component formed through the shikimic acid pathway, is one of the main characteristic aroma components of lily (Fan Yanping, 2008).
苯甲酸乙酯是苯丙酸类化合物/苯环型化合物,它是以L-苯丙氨酸前体的。在质体中通过莽草酸途径产生苯丙氨酸,在苯丙氨酸裂解酶(PAL)的催化作用下生成肉桂酸。肉桂酸在一系列酶的催化作用下合成苯甲醛、苯甲酸,在苯甲酸辅酶A连接酶(BZL)作用下,苯甲酸形成苯甲酰CoA (Boatright J. et al,2004),最后在醇酰基转移酶(AAT)催化下生成,该酶是控制苯甲酸乙酯形成的末端关键酶。 Ethyl benzoate is a phenylpropionic acid compound/benzene ring compound, which is a precursor of L-phenylalanine. In plastids, phenylalanine is produced through the shikimate pathway, and cinnamic acid is catalyzed by phenylalanine lyase (PAL). Cinnamic acid is catalyzed by a series of enzymes to synthesize benzaldehyde and benzoic acid. Under the action of benzoic acid coenzyme A ligase (BZL), benzoic acid forms benzoyl CoA (Boatright J. et al , 2004), and finally in alcohol It is produced under the catalysis of acyltransferase (AAT), which is the terminal key enzyme that controls the formation of ethyl benzoate.
Nordstrom(1962)首次指出酵母中酯类合成主要依靠酰基转移酶或酯合成酶的作用。到目前为止,已从不同的酵母中克隆出三个不同的醇酰基转移酶基因。花和果实是植物体中酯类挥发性成分合成的主要器官,成熟酯类挥发性成分构成了花和果实特有的香气,这一过程也与醇酰基转移酶有关。Ueda 和Ogata(1977)发现香蕉细胞提取液中的酯类挥发性香气成分的合成依赖酰基CoA和酰基转移酶。此后,人们在草莓、苹果、菠萝、甜瓜等水果中研究了醇酰基转移酶与酯类挥发性物质合成之间的关系。这些果实中酯类物质的形成都是在醇酰基转移酶的作用下,将酰基CoAs中的酰基转移到醇类底物形成了酯。Perez et al.(1993)对4个草莓品种果实成熟期间AAT活性的研究表明,各品种AAT活性均随果实成熟而增加,但不同品种最大活性差异很大。Shalit et al.(2001)的研究表明,富有香气的甜瓜品种‘Arava’成熟果实与未熟果实中香气挥发性成分组成显著不同。 Nordstrom (1962) pointed out for the first time that ester synthesis in yeast mainly depends on the action of acyltransferase or ester synthase. So far, three different alcohol acyltransferase genes have been cloned from different yeasts. Flowers and fruits are the main organs for the synthesis of volatile esters in plants. The mature volatile esters constitute the unique aroma of flowers and fruits. This process is also related to alcohol acyltransferase. Ueda and Ogata (1977) found that the synthesis of volatile aroma components of esters in banana cell extract depends on acyl-CoA and acyltransferase. Since then, people have studied the relationship between alcohol acyltransferase and the synthesis of volatile esters in strawberry, apple, pineapple, melon and other fruits. The formation of esters in these fruits is due to the action of alcohol acyltransferase, which transfers the acyl group in the acyl CoAs to the alcohol substrate to form an ester. Perez et al. (1993) studied the AAT activity of four strawberry varieties during fruit ripening, showing that the AAT activity of each variety increased with fruit ripening, but the maximum activity of different varieties varied greatly. Shalit et al. (2001) showed that the composition of aroma volatile components was significantly different between ripe and unripe fruits of the aroma-rich melon cultivar 'Arava'.
近年来,随着生物技术的发展,已经在花和果实中克隆了几个醇酰基转移酶基因。研究发现,这些结构和功能类似的酶是酰基转移酶类(EC 2.3.1.x)进化来的一个新类别,都属于酰基转移酶类的BAHD基因家族。植物中最早分离出的醇酰基转移酶基因来自Clarkia breweri花,BEAT编码苯甲醇乙酰转移酶,调控了乙酸苯甲酯的代谢,属于酰基转移酶的BAHD家族(Dudareva et al,1998)。D’Auria et al.(2002)采用表达序列标签(EST)文库搜索结合cDNA 末端快速扩增(RACE)技术从仙女扇中获得了BEBT的cDNA的全长。该基因与植物酰基转移酶基因序列具有很大的同源性,属于酰基转移酶中的BAHD家族。BEBT在花和受伤的叶片中都有表达,表明苯甲酸苄酯在植物防御机制中也起一定作用。 In recent years, with the development of biotechnology, several alcohol acyltransferase genes have been cloned in flowers and fruits. The study found that these structurally and functionally similar enzymes are a new category evolved from acyltransferases (EC 2.3.1.x), and all belong to the BAHD gene family of acyltransferases. The earliest alcohol acyltransferase gene isolated in plants came from the flower of Clarkia breweri . BEAT encodes benzyl alcohol acetyltransferase, which regulates the metabolism of benzyl acetate, and belongs to the BAHD family of acyltransferases (Dudareva et al , 1998). D'Auria et al. (2002) obtained the full-length cDNA of BEBT from fairy fan by using expressed sequence tag (EST) library search combined with rapid amplification of cDNA ends (RACE). The gene has great homology with the plant acyltransferase gene sequence, and belongs to the BAHD family of acyltransferases. BEBT was expressed in both flowers and injured leaves, suggesting that benzyl benzoate also plays a role in plant defense mechanisms.
Aharoni et al.(2000)首次采用表达序列标签(EST)文库搜索结合植物挥发性成分谱,利用cDNA 芯片从成熟草莓果实中分离了一个新的与芳香气味相关的醇酰基转移酶基因SAAT。它具有催化中链脂肪酸乙酸酯形成的能力。在Charentais甜瓜中克隆出两个具有高度同源性(87%,在蛋白水平确定)的醇酰基转移酶基因,CM-AAT1(GenBank CAA94432)和CM-AAT2(GenBank AF468022),编码461个氨基酸,分子量分别为51.5KD和51.8 KD,pI分别为8和8.5。转化酵母发现CM-AAT1具有合成酯类挥发性成分的能力,而CM-AAT2没有检测到醇酰基转移酶活性。Shalit et al.(2003)在含有1834个单基因的玫瑰花EST数据库中检索,发现3个可能的EST序列与已知的其它来源的BAHD醇酰基转移酶基因相似。其中一个cDNA被命名为RhAAT1,编码一个458个氨基酸残基的多肽,其分子量51.8 KD,pI 5.45,属于BAHD酰基转移酶家族。通过同源性比较,这个蛋白序列与草莓SAAT蛋白具有69%的同源性。Boatright et al.(2004)在对矮牵牛的研究中,运用功能基因组学的方法克隆出苯甲醇/苯基乙醇苯甲酰转移酶基因(BPBT)。该基因的氨基酸序列与烟草的BEBT基因和仙女扇的BEAT都具有较高的同源性。苯甲醇/苯乙醇苯甲酰基转移酶以苯甲酰辅酶A为苯甲酰基供体,以苯甲醇和苯基乙醇为前体,将苯甲酰基转移至苯甲醇和苯乙醇上,形成苯甲酸苄酯和苯甲酸苯乙酯。Li et al.(2006)通过RT-PCR和RACE-PCR技术分离了乔纳金苹果和金冠苹果果实中的醇酰基转移酶基因,分别命名为MdAAT1和MdAAT2。其全长分别为:1,639 bp和1,628 bp,二者在氨基酸水平上的同源性为94.26%。序列比对发现MdAAT2也含有BAHD基因家族和其它已知醇酰基转移酶基因共有的保守区:HXXXD和FGWG。聚类分析发现,MdAAT2蛋白与同属蔷薇科仁果类的梨果实醇酰基转移酶蛋白亲缘关系最近,而与柠檬、草莓、玫瑰花等醇酰基转移酶蛋白亲缘关系较远。此外,Yoshioka和Hashimoto(1981)在酵母研究中发现醇酰基转移酶是定位在细胞膜上,并对该酶的酶学特性进行了初步的研究。D’Auria(2002)认为大部分BAHD家族的成员被认为定位于细胞质。Fujiwara et al.(1998)对三花龙胆(Gentiana triflora)的5-O-葡萄糖苷芳香族酰基转移酶进行免疫定位研究发现其主要分布于上表皮细胞的细胞质中。然而Yu et al.(2008)发现蒺藜苜蓿(Medicago truncatula)中的BAHD家族的MtMaT1则是定位于细胞核中。 Aharoni et al. (2000) used expressed sequence tag (EST) library search combined with plant volatile component profiles for the first time to isolate a new alcohol acyltransferase gene SAAT related to aroma odor from ripe strawberry fruit using cDNA chip. It has the ability to catalyze the formation of medium-chain fatty acid acetates. Two highly homologous (87%, determined at the protein level) alcohol acyltransferase genes, CM-AAT1 (GenBank CAA94432) and CM-AAT2 (GenBank AF468022), encoding 461 amino acids, were cloned from Charentais melon. The molecular weights are 51.5KD and 51.8 KD, respectively, and the pIs are 8 and 8.5, respectively. Transformed yeast found that CM-AAT1 had the ability to synthesize volatile components of esters, while CM-AAT2 had no alcohol acyltransferase activity. Shalit et al. (2003) searched the rose flower EST database containing 1834 single genes and found 3 possible EST sequences similar to known BAHD alcohol acyltransferase genes from other sources. One of the cDNAs was named RhAAT 1, which encoded a polypeptide of 458 amino acid residues, with a molecular weight of 51.8 KD and a pI of 5.45, belonging to the BAHD acyltransferase family. Through homology comparison, this protein sequence has 69% homology with strawberry SAAT protein. Boatright et al. (2004) used functional genomics to clone the benzyl alcohol/phenyl alcohol benzoyltransferase gene ( BPBT ) in the study of petunias. The amino acid sequence of the gene has high homology with BEBT gene of tobacco and BEAT of fairy fan. Benzyl alcohol/phenylethyl alcohol benzoyltransferase uses benzoyl-CoA as a benzoyl donor and uses benzyl alcohol and phenyl ethanol as precursors to transfer benzoyl to benzyl alcohol and phenyl alcohol to form benzoic acid Benzyl esters and phenethyl benzoate. Li et al. (2006) isolated alcohol acyltransferase genes from Jonagold and Golden Delicious apples by RT-PCR and RACE-PCR, and named them MdAAT 1 and MdAAT 2, respectively. The full lengths are 1,639 bp and 1,628 bp, respectively, and the homology between the two at the amino acid level is 94.26%. Sequence alignment revealed that MdAAT 2 also contains the conserved regions shared by the BAHD gene family and other known alcohol acyltransferase genes: HXXXD and FGWG. Cluster analysis found that the MdAAT2 protein had the closest relationship with the alcohol acyltransferase protein of pear fruit, which belongs to the Rosaceae pome fruit, but had a distant relationship with the alcohol acyltransferase proteins of lemon, strawberry and rose. In addition, Yoshioka and Hashimoto (1981) found that alcohol acyltransferase is located on the cell membrane in yeast research, and carried out preliminary research on the enzymatic characteristics of the enzyme. D'Auria (2002) suggested that most members of the BAHD family are thought to be located in the cytoplasm. Fujiwara et al. (1998) conducted an immunolocalization study on 5-O-glucoside aromatic acyltransferase of Gentiana triflora and found that it was mainly distributed in the cytoplasm of epidermal cells. However, Yu et al. (2008) found that MtMaT1 of the BAHD family in Medicago truncatula ( Medicago truncatula ) was localized in the nucleus.
近年来,植物花香次生生物合成的基因操作已成为一个热门的研究领域。Guterman et al.(2006)将从月季中克隆的AAT也导入矮牵牛中,结果在转基因植株中产生乙酸卞酯和乙酸苯乙酯。这为采用基因工程技术培育香花品种提供了一条有效的途径。 In recent years, genetic manipulation of secondary biosynthesis of plant floral fragrance has become a hot research area. Guterman et al. (2006) also introduced the AAT cloned from rose into petunia, resulting in the production of benzyl acetate and phenylethyl acetate in the transgenic plants. This provides an effective way for cultivating fragrant flower varieties by genetic engineering technology.
发明内容 Contents of the invention
目前,国内对醇酰基转移酶与花香形成的研究鲜见报道,直到本专利申请前没有发现对百合花香基因报道。克隆花香基因是对百合花香形成机理研究的前提,揭示百合花香的分子机理可以增加花香。这为采用基因工程的方法培育具浓郁花香植物新品种提供了一条崭新的途径。本发明的目的是分离克隆西伯利亚百合百合花中携带的一个控制酯类花香成分苯甲酸乙酯的基因。 At present, domestic studies on alcohol acyltransferase and the formation of floral fragrance are rarely reported, and no report on lily flower fragrance gene was found until this patent application. The cloning of the floral fragrance gene is the premise of the study on the formation mechanism of lily fragrance, revealing the molecular mechanism of lily fragrance can increase the floral fragrance. This provides a brand-new approach for cultivating new varieties of plants with strong floral fragrance by means of genetic engineering. The purpose of the present invention is to isolate and clone a gene controlling ester floral fragrance component ethyl benzoate carried in Lilium siberia lily. the
本发明另一目的在于提供上述基因编码的蛋白质。 Another object of the present invention is to provide the protein encoded by the above gene. the
本发明另一目的在于提供含有上述基因的载体。 Another object of the present invention is to provide a vector containing the above gene. the
本发明另一目的在于提供含有上述载体的转基因植物。 Another object of the present invention is to provide a transgenic plant containing the above vector. the
本发明还有一个目的在于提供上述基因在产生分子标记及其在选育对花香品种中的应用,以及上述基因编码的蛋白质在制备香精和药物中的应用。 Another object of the present invention is to provide the application of the above-mentioned gene in producing molecular markers and breeding varieties for flower fragrance, and the application of the protein encoded by the above-mentioned gene in the preparation of essence and medicine. the
本发明通过以下技术方案予以实现上述目的: The present invention achieves the above-mentioned purpose through the following technical solutions:
一种百合酯类花香基因LoAAT1,所述基因的全长cDNA序列如SEQ ID NO:1所示,全长cDNA序列长1380bp;基因的全长DNA序列如SEQ ID NO:2所示,全长DNA序列长1472bp。 A lily ester floral fragrance gene LoAAT1 , the full-length cDNA sequence of the gene is shown in SEQ ID NO:1, and the full-length cDNA sequence is 1380bp in length; the full-length DNA sequence of the gene is shown in SEQ ID NO:2, the full-length The DNA sequence is 1472bp long.
百合酯类花香基因LoAAT1赋予姜花花朵沉香醇香味,而且百合酯类花香基因LoAAT1在有香味的百合花组织表达,在无香味的百合品种中不表达,并且其表达与花发育进程有关。该基因基因编码区共1380bp(即全长cDNA序列),推测其编码459个氨基酸,蛋白分子量为50 kDa。在这个基因序列中有HXXXD和DFGWG两个保守序列, DNA全长核苷酸序列长度为1472bp,包含1个内含子,位于第442~533位,共有92bp,且剪切位置均符合“GT-AG法则”。通过原核表达并用反应底物乙醇和苯甲酰辅酶A反应体外生成苯甲酸乙酯。 The lily ester floral aroma gene LoAAT1 endows ginger flowers with agarwood and mellow aroma, and the lily ester floral aroma gene LoAAT1 is expressed in scented lily tissues, but not in non-scented lily varieties, and its expression is related to the flower development process. The coding region of the gene is 1380bp (full-length cDNA sequence), and it is presumed that it encodes 459 amino acids, and the protein molecular weight is 50 kDa. In this gene sequence, there are two conserved sequences, HXXXD and DFGWG. The full-length nucleotide sequence of the DNA is 1472bp in length, including 1 intron, located at positions 442-533, with a total of 92bp, and the cut positions all conform to the "GT -AG Law". Ethyl benzoate was produced in vitro by prokaryotic expression and reacted with reaction substrate ethanol and benzoyl-CoA.
一种百合酯类花香基因LoAAT1编码的蛋白质,所述蛋白的氨基酸序列如SEQ ID NO:3所示。 A protein encoded by the lily ester floral fragrance gene LoAAT1 , the amino acid sequence of the protein is shown in SEQ ID NO:3.
一对用于扩增百合酯类花香基因LoAAT1的引物,引物序列如SEQ ID NO:10~11所示。 A pair of primers for amplifying the lily ester floral aroma gene LoAAT1 , the primer sequences are shown in SEQ ID NO: 10-11.
一种重组载体,在出发载体的多克隆位点插入,权利要求1所述百合酯类花香基因LoAAT1的序列。所述出发载体可以是本技术领域中经常用到的所有类型的植物表达载体,优选地,本发明所用的植物表达载体为pMOGMON植物表达载体。 A recombinant vector, inserted into the multi-cloning site of the departure vector, the sequence of the lily ester floral fragrance gene LoAAT1 described in claim 1. The starting vector can be all types of plant expression vectors commonly used in this technical field. Preferably, the plant expression vector used in the present invention is pMOGMON plant expression vector.
一种包含如上所述重组载体的重组菌。 一种包含如上所述重组载体的细胞系。 A recombinant bacterium comprising the above-mentioned recombinant vector. A cell line comprising a recombinant vector as described above. the
一种转基因植物,含有如上所述载体。 A transgenic plant containing the above-mentioned vector. the
如上所述百合酯类花香基因LoAAT1的应用,具体为将百合酯类花香基因LoAAT1连接到植物转化载体中,然后导入百合或其它植物细胞中,获得表达所述百合酯类花香基因LoAAT1的转基因花香品种。 As mentioned above, the application of the lily ester floral aroma gene LoAAT1 is specifically connecting the lily ester floral aroma gene LoAAT1 to a plant transformation vector, and then introducing it into lily or other plant cells to obtain a transgenic floral aroma expressing the lily ester floral aroma gene LoAAT1 Variety.
如上所述百合酯类花香基因LoAAT1的应用,具体为根据该基因产生特异性的分子标记,用于鉴定百合或其它植物的花香基因型。 As mentioned above, the application of the lily ester floral aroma gene LoAAT1 is specifically to generate a specific molecular marker based on the gene, which is used to identify the floral aroma genotype of lily or other plants.
如上所述百合酯类花香基因LoAAT1编码的蛋白质在制备香精和药物中的应用。 As mentioned above, the application of the protein encoded by the lily ester floral aroma gene LoAAT1 in the preparation of essence and medicine.
本发明同样包括将LoAAT1花香基因的主要结构部分有效地连接上合适的调节序列所形成的嵌合基因,以及在基因组中包含这种基因的植物和这种植物的种子。如这种基因可以是天然的或是嵌合的。例如,将包含该基因的片段和一个组成型表达的启动子连接,该启动子可以在任何条件下和细胞发育的任何时期表达。这种组成型表达的启动子包括花椰菜花叶病毒35S的启动子等。另一方面,也可以将该基因和一个组织特异性表达的启动子或发育时期特异性表达的启动子或精确环境诱导的启动子连接,这些启动子称之为诱导型启动子。这样,环境的改变,发育时期的不同都可以改变该基因的表达,同样,也可以将该基因的表达限定在某一个组织内,使由该基因诱导的抗性反应得到人为的控制。其中环境条件包含病虫害的攻击、高低温和光等,组织和发育时期包括叶、果实、种子和花等。 The present invention also includes the chimeric gene formed by effectively linking the main structural part of the LoAAT1 floral fragrance gene with a suitable regulatory sequence, as well as the plant containing the gene in the genome and the seeds of the plant. Such genes may be natural or chimeric, for example. For example, a fragment comprising the gene is linked to a constitutively expressed promoter which can be expressed under any condition and at any stage of cell development. Such constitutively expressed promoters include the cauliflower mosaic virus 35S promoter and the like. On the other hand, the gene can also be linked to a tissue-specific expression promoter or a developmental stage-specific expression promoter or a precise environment-induced promoter, these promoters are called inducible promoters. In this way, changes in the environment and different developmental stages can change the expression of the gene. Similarly, the expression of the gene can also be limited to a certain tissue, so that the resistance response induced by the gene can be artificially controlled. The environmental conditions include the attack of diseases and insect pests, high and low temperature and light, etc., and the tissue and developmental stages include leaves, fruits, seeds and flowers.
根据本发明提供的LoAAT1基因序列信息,本领域技术人员可以通过以下方法容易地获得与LoAAT1等同的基因:(1)通过数据库检索获得;(2)以LoAAT1基因片段为探针筛选姜花或其它植物的基因组文库或cDNA文库获得;(3)根据LoAAT1基因序列信息设计寡核苷酸引物,用PCR扩增的方法从姜花或其它植物的基因组、mRNA和cDNA中获取;(4)在LoAAT1基因序列的基础上用基因工程方法改造获得;(5)用化学合成的方法获得该基因。 According to the LoAAT1 gene sequence information provided by the present invention, those skilled in the art can easily obtain the gene equivalent to LoAAT1 by the following methods: (1) obtain by searching the database; (2) use the LoAAT1 gene fragment as a probe to screen ginger flower or other (3) Design oligonucleotide primers according to the LoAAT1 gene sequence information, and use PCR amplification method to obtain from the genome, mRNA and cDNA of ginger flower or other plants; (4) LoAAT1 (5) The gene is obtained by chemical synthesis.
本发明提供的百合花香基因LoAAT1具有重要的应用价值。应用之一是将所述的LoAAT1基因序列连接到任何一种植物转化载体,用任何一种转化方法将LoAAT1花香基因导入百合或其他植物细胞,可获得表达所述基因的转基因花香,从而应用于生产。本发明所述的基因构建到植物转化载体中,可以对所述基因或其调控序列适当修饰,也可以在其转录起始密码子前用其它启动子取代所述基因原有的启动子,从而拓宽和增强植物产生花香和增强抗性的能力。 The lily fragrance gene LoAAT1 provided by the invention has important application value. One of the applications is to connect the LoAAT1 gene sequence to any plant transformation vector, and use any transformation method to introduce the LoAAT1 floral fragrance gene into lily or other plant cells, and obtain transgenic floral fragrance expressing the gene, so as to be applied to Production. The gene of the present invention is constructed into a plant transformation vector, the gene or its regulatory sequence can be appropriately modified, and other promoters can be used to replace the original promoter of the gene before its transcription start codon, thereby Broadens and enhances the plant's ability to produce floral fragrance and increase resistance.
本发明提供的花香基因的另一个应用是根据所述基因序列信息产生特异性的分子标记,包括但不限于SNP(单核苷酸多态)、SSR(简单序列重复多态)、RFLP(限制性内切酶长度多态)、CAP(切割扩增片段多态)。用这些标记可鉴定百合或其它植物的花香基因型,用于分子标记辅助选择育种,从而提高育种的选择效率。 Another application of the floral fragrance gene provided by the present invention is to generate specific molecular markers based on the gene sequence information, including but not limited to SNP (single nucleotide polymorphism), SSR (simple sequence repeat polymorphism), RFLP (restricted endonuclease length polymorphism), CAP (cleavage amplified fragment polymorphism). These markers can be used to identify the floral genotypes of lilies or other plants, and can be used in molecular marker-assisted selection breeding, thereby improving the selection efficiency of breeding. the
与现有技术相比,本发明具有以下有益效果: Compared with the prior art, the present invention has the following beneficial effects:
本发明将克隆的花香基因转入无花香的植物,有助于产生新的花香植物。特别是可以用转化技术在植物中累加多个花香基因,而不会产生传统育种技术中伴随出现的基因组中不良基因的连锁问题,并且可以缩短育种时间。花香基因的克隆是克服传统育种中不能在植物种间转移花香基因的问题的前提。另外,本发明能够进一步提供或应用利用上述DNA片段获得的花香的转基因植株和相应的种子,以及用本发明的基因或基于该基因的重组体转化的植株或由这类植株获得的种子。可以用有性杂交的方式将本发明的基因转入其他的植株。 The invention transfers the cloned floral fragrance gene into the non-floral fragrance plant, which helps to produce new floral fragrance plants. In particular, transformation technology can be used to accumulate multiple floral fragrance genes in plants, without causing the linkage problem of bad genes in the genome that is accompanied by traditional breeding technology, and can shorten the breeding time. The cloning of the floral fragrance gene is the premise to overcome the problem that the floral fragrance gene cannot be transferred between plant species in traditional breeding. In addition, the present invention can further provide or use floral transgenic plants and corresponding seeds obtained using the above-mentioned DNA fragments, as well as plants transformed with the gene of the present invention or a recombinant based on the gene or seeds obtained from such plants. The gene of the present invention can be transferred to other plants by means of sexual crossing.
说明书附图Instructions attached
图1. LoAAT1在花香苯甲酸乙酯释放量不同的百合品种中的表达;A:百合花瓣花香主成分苯甲酸乙酯的释放量;B:百合花瓣LoATT1表达水平;C:不同的百合品种。 Figure 1. The expression of LoAAT1 in lily cultivars with different release amounts of floral fragrance ethyl benzoate; A: release amount of ethyl benzoate, the main component of floral fragrance from lily petals; B: expression level of LoATT1 in lily petals; C: different lily cultivars.
图2. LoAAT1在花器官不同发育时期的表达和不同组织表达特异性;A:Siberia百合不同器官LoAAT1表达水平;B:Siberia百合花朵不同花发育时期苯甲酸乙酯的释放量;C:Siberia百合不同开花时期;D:Siberia百合花瓣LoAAT1表达量;E:Siberia百合花萼LoAAT1表达量;F:Siberia百合雄蕊LoAAT1表达量;G:Siberia百合雌蕊LoAAT1表达量。 Figure 2. The expression of LoAAT1 in different developmental stages of floral organs and the specificity of expression in different tissues; A: the expression level of LoAAT1 in different organs of Lily Siberia; B: the release of ethyl benzoate in different flower development stages of Lilium Siberia; C: Lilium Siberia Different flowering stages; D: the expression level of LoAAT1 in Lily Siberia petals; E: the expression level of LoAAT1 in calyx of Lily Siberia; F: the expression level of LoAAT1 in stamens of Lily Siberia; G: the expression level of LoAAT1 in pistils of Lily Siberia.
图3. LoAAT1重组蛋白体外酶催化反应;A:pET-28a- LoAAT1重组蛋白体外酶催化反应产物色谱和质谱分析图;B: 苯甲酸乙酯标样色谱和质谱分析图。 Figure 3. In vitro enzyme-catalyzed reaction of LoAAT1 recombinant protein; A: Chromatogram and mass spectrogram of pET-28a- LoAAT1 recombinant protein in vitro enzyme-catalyzed reaction product; B: Chromatogram and mass spectrometry of ethyl benzoate standard sample.
图4. LoAAT1转基因烟草植株的PCR检测图。 Figure 4. PCR detection chart of LoAAT1 transgenic tobacco plants.
具体实施方式 Detailed ways
下面结合附图和具体实施例进一步详细说明本发明。除非特别说明,实施例中采用的试剂和方法均为本领域常规使用的试剂和方法。 The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments. Unless otherwise specified, the reagents and methods used in the examples are those routinely used in the art. the
实施例1 LoAAT1基因cDNA和DNA全长的获得: Example 1 Acquisition of LoAAT1 gene cDNA and full-length DNA:
S1.百合花瓣RNA的提取:称取0.2g百合盛开期花瓣,加液氮迅速研磨成粉末状,快速转入4℃存放的加有0.5 mL2 % CTAB(含0.1%的巯基乙醇)提取液的2 mL离心管中,振荡至彻底混匀;室温放置5min,平放离心管,使表面积最大;4℃ 12000rpm离心1min,上清转入新的无RNase离心管。加入0.1mL5M NaCl,温和混匀;加入0.3mL氯仿,上下颠倒混匀;4℃ 12000rpm离心10min,取上层水相转入新的无RNase离心管。加入与所得水相等体积的预冷的异丙醇,颠倒混匀,室温放置10min,平放离心管,使表面积最大;4℃ 12000 rpm离心10min,弃掉上清,注意不要倒出沉淀,加1 mL 75%乙醇(DEPC水配制)洗涤RNA沉淀,颠倒混匀;4℃ 5000 rpm离心3min,倒出液体,注意不要倒出沉淀。剩余的少量液体短暂离心,然后用枪头吸出,室温晾干2~3 min;加入30μL DEPC H2O,反复吹打,混匀,充分溶解RNA。放于-80℃保存备用。 S1. Extraction of lily petal RNA: Weigh 0.2 g of lily petals in full bloom, add liquid nitrogen and quickly grind them into powder, and quickly transfer to 0.5 mL 2 % CTAB (containing 0.1% mercaptoethanol) extract stored at 4 °C. In a 2 mL centrifuge tube, shake until thoroughly mixed; place at room temperature for 5 minutes, lay the centrifuge tube flat to maximize the surface area; centrifuge at 12,000 rpm at 4°C for 1 min, and transfer the supernatant to a new RNase-free centrifuge tube. Add 0.1mL 5M NaCl, mix gently; add 0.3mL chloroform, mix upside down; centrifuge at 12000rpm at 4°C for 10min, transfer the upper aqueous phase to a new RNase-free centrifuge tube. Add pre-cooled isopropanol equal to the volume of the obtained water, invert and mix well, place at room temperature for 10 minutes, place the centrifuge tube horizontally to maximize the surface area; centrifuge at 12000 rpm at 4°C for 10 minutes, discard the supernatant, be careful not to pour out the precipitate, add Wash the RNA pellet with 1 mL of 75% ethanol (prepared with DEPC water), invert and mix well; centrifuge at 5000 rpm at 4°C for 3 minutes, pour out the liquid, and be careful not to pour out the pellet. The remaining small amount of liquid was briefly centrifuged, then sucked out with a pipette tip, and dried at room temperature for 2-3 minutes; 30 μL DEPC H 2 O was added, and the RNA was fully dissolved by pipetting and mixing repeatedly. Store at -80°C for later use.
S2.以百合盛开期的花瓣总RNA作为模板,用生工M-MuLV First cDNA Synthesis Kit合成第一链cDNA。据GenBank 核酸数据库中报道的相关基因序列设计引物,上游引物F1:TCTCCAAGGCTCTGGTGTTCTA(T/C)TA(T/C) CC(A/C/G/T)(G/T/C)T;如SEQ ID NO:4所示。下游引物R1:TGCATGAACCTGATAGCGAAG(A/G)(T/C)(A/G)AA(A/C/G/T)CC(A/C/G/T )CC;如SEQ ID NO:5所示。并交由上海生物工程公司合成。以上述合成的cDNA为模板采用TaKaRa PCR Amplification Kit进行PCR扩增反应,具体方法按照说明书进行。PCR程序为:94℃预变性4min;94℃变性30s、57℃复性30s、72℃延伸1min,30个循环;然后72℃延伸10min。在-20℃下保存备用。PCR反应结束后,用1.0%琼脂糖凝胶电泳初步检测PCR产物中是否含有目的片段条带。PCR扩增产物经1%琼脂糖凝胶电泳检测后,用手术刀在紫外灯下切出含有目的片段的胶块,用DNA凝胶回收试剂盒(Agarose Gel DNA Purification Kit,TaKaRa)进行回收,回收方法基本参照试剂盒说明书。之后要对回收产物进行1%琼脂糖电泳检测,看其回收效果及大致浓度,以便保证后续试验的进行。根据回收的目的片段大小及其有效浓度,取适量回收纯化的产物与克隆载体连接,载体选用TaKaRa pMD18-T载体,目的DNA与克隆载体的摩尔比控制在3:1左右,具体操作按说明书进行。在16℃下恒温连接3~6h,连接时间的长短视目的片段的长度而定。提前将感受态细胞DH5α(TaKaRa)从-80℃冰箱取出,并置于冰盒中待其自然融化,将10μL连接液全量加入感受态细胞的离心管中,冰浴30min后,42℃水浴热激50s,迅速冰上放置2~5min,然后加入37℃预温的SOC液体培养基890μL补足到1mL,混匀后37℃下180rpm振荡培养1h。在含100μg/mL氨苄青霉素的LB固体培养基平板表面上涂30μL的X-gal(20mg/mL)和30μL IPTG(20mg/mL),然后涂布适量转化液,待转化液完全被吸收后倒置于37℃恒温箱中过夜培养,约16h后观察结果,通过X-gal/IPTG蓝白斑筛选白色菌落,并初步鉴定重组质粒,平板置于4℃保存。通过蓝白斑初步筛选后,通常选6个菌斑摇菌后提取质粒,用于进一步鉴定。用灭菌的牙签从LB平板培养基上挑取白色单菌落接种于含有100μg/mL氨苄青霉素的LB液体培养基中,于控温震荡水浴摇床上37℃、240rpm振荡过夜培养,用质粒DNA小抽试剂盒(上海博亚生物有限公司)提取质粒,步骤按说明书上方法进行。对所提质粒进行1.0%琼脂糖凝胶电泳检测,比较质粒大小并将明显滞后的质粒进行双酶切(EcoRⅠ/HindⅢ,TaKaRa)分析。在37℃下酶切1h后,对酶切产物进行1.0%琼脂糖凝胶电泳检测。随意选送酶切鉴定后含目的片段的重组质粒进行DNA序列测定。测序工作交由上海英骏生物技术有限公司完成,采用美国ABI377序列分析仪。所得的序列在NCBI进行比对和同源性分析。 S2. The first-strand cDNA was synthesized with Sangon's M-MuLV First cDNA Synthesis Kit using the total petal RNA of lily at the blooming stage as a template. Primers were designed according to the relevant gene sequences reported in the GenBank nucleic acid database, upstream primer F1: TCTCCAAGGCTCTGGTGTTCTA(T/C)TA(T/C)CC(A/C/G/T)(G/T/C)T; such as SEQ ID NO:4 shown. Downstream primer R1: TGCATGAACCTGATAGCGAAG(A/G)(T/C)(A/G)AA(A/C/G/T)CC(A/C/G/T)CC; as shown in SEQ ID NO:5 . And it was synthesized by Shanghai Bioengineering Company. Using the cDNA synthesized above as a template, PCR amplification reaction was carried out using TaKaRa PCR Amplification Kit, and the specific method was carried out according to the instructions. The PCR program was: 94°C pre-denaturation for 4 minutes; 30 cycles of denaturation at 94°C for 30 s, annealing at 57°C for 30 s, and extension at 72°C for 1 min; then extension at 72°C for 10 min. Store at -20°C for later use. After the PCR reaction, 1.0% agarose gel electrophoresis was used to preliminarily detect whether the PCR product contained the target fragment band. After the PCR amplification product was detected by 1% agarose gel electrophoresis, the gel block containing the target fragment was cut out with a scalpel under ultraviolet light, and the DNA gel recovery kit (Agarose Gel DNA Purification Kit, TaKaRa) was used for recovery. The method basically refers to the kit instructions. Afterwards, 1% agarose electrophoresis should be carried out on the recovered product to see its recovery effect and approximate concentration, so as to ensure the subsequent test. According to the size of the recovered target fragment and its effective concentration, take an appropriate amount of the recovered and purified product and connect it to the cloning carrier. The carrier is the TaKaRa pMD18-T carrier. The molar ratio of the target DNA to the cloning carrier is controlled at about 3:1. The specific operation is carried out according to the instructions. . Connect at a constant temperature of 16°C for 3-6 hours, and the length of the connection time depends on the length of the target fragment. Take the competent cell DH5α (TaKaRa) out of the -80°C refrigerator in advance, and put it in the ice box until it melts naturally, add 10 μL of the connection solution to the centrifuge tube of the competent cell, and after ice bathing for 30 minutes, heat it in a 42°C water bath. Stimulate for 50 s, quickly place on ice for 2-5 min, then add 890 μL of SOC liquid medium pre-warmed at 37 °C to make up to 1 mL, mix well, and shake at 180 rpm at 37 °C for 1 h. Apply 30 μL of X-gal (20 mg/mL) and 30 μL of IPTG (20 mg/mL) on the surface of LB solid medium plate containing 100 μg/mL ampicillin, then apply an appropriate amount of transformation solution, and invert after the transformation solution is completely absorbed Cultivate overnight in a 37°C incubator, observe the results after about 16 hours, screen the white colonies by X-gal/IPTG blue and white spots, and initially identify the recombinant plasmid, and store the plate at 4°C. After passing the preliminary screening of blue and white spots, usually 6 plaques were selected and shaken to extract plasmids for further identification. Use a sterilized toothpick to pick a white single colony from the LB plate culture medium and inoculate it in the LB liquid medium containing 100 μg/mL ampicillin, and culture it overnight on a temperature-controlled shaking water bath shaker at 37°C and 240 rpm. The extraction kit (Shanghai Boya Biological Co., Ltd.) was used to extract the plasmid, and the steps were carried out according to the method in the manual. The extracted plasmids were detected by 1.0% agarose gel electrophoresis, the sizes of the plasmids were compared, and the plasmids that were obviously lagging behind were analyzed by double enzyme digestion ( EcoR Ⅰ/ Hind Ⅲ, TaKaRa). After digestion at 37°C for 1 h, the digested products were detected by 1.0% agarose gel electrophoresis. Recombinant plasmids containing target fragments were randomly selected and identified for DNA sequence determination. The sequencing work was completed by Shanghai Yingjun Biotechnology Co., Ltd., using the American ABI377 sequence analyzer. The resulting sequences were aligned and homology analyzed at NCBI.
根据已得到的cDNA片段序列,利用生物软件Primer Premier 5.0在靠近片段序列的3′端设计两个特异引物,3′-RACE 1st Primer:GAGTTGCTCTTCGACGTTGAG;如SEQ ID NO:6所示;3′-RACE 2nd Primer:CGCTGATCCTAATTCAGGTGACTC;如SEQ ID NO:7所示。经生物软件Oligo 6.0分析后交由上海生物工程公司合成。以Oligo(dT)-3′末端锚定引物为引物,反转录合成cDNA第一链。将合成的cDNA第一链作为模板,用3′一回引物与3′末端锚定引物进行3′末端PCR 扩增。PCR程序为:94℃预变性3min;94℃变性30s、复性30s(温度视具体而定)、72℃延伸1min,30个循环;然后72℃总延伸10min。第一次PCR反应液稀释10-100倍后作为模板,用3′二回巢式引物进行第二次PCR反应。PCR反应结束后,用1.0%琼脂糖凝胶电泳初步检测PCR产物中是否含有目的片段条带。经过回收、检测,随机选送酶切鉴定后含目的片段的重组质粒进行DNA序列测定。测序工作交由上海英骏生物技术有限公司完成,采用美国ABI377序列分析仪。把测序结果与cDNA片段的序列进行拼接分析,判断其是否是cDNA片段序列3′的延伸。 According to the obtained cDNA fragment sequence, use the biological software Primer Premier 5.0 to design two specific primers near the 3′ end of the fragment sequence, 3′-RACE 1st Primer: GAGTTGCTCTTCGACGTTGAG; as shown in SEQ ID NO: 6; 3′-RACE 2nd Primer: CGCTGATCCTAATTCAGGTGACTC; as shown in SEQ ID NO:7. After being analyzed by biological software Oligo 6.0, it was synthesized by Shanghai Bioengineering Company. The first strand of cDNA was synthesized by reverse transcription with the Oligo(dT)-3' end anchor primer as a primer. The first strand of the synthesized cDNA was used as a template, and the 3' end PCR was amplified with the 3' primary primer and the 3' end anchor primer. The PCR program is: pre-denaturation at 94°C for 3 minutes; 30 cycles of denaturation at 94°C for 30 s, renaturation for 30 s (depending on the temperature), extension at 72°C for 1 min, and a total extension at 72°C for 10 min. The first PCR reaction solution was diluted 10-100 times as a template, and the second PCR reaction was carried out with 3' double nested primers. After the PCR reaction, 1.0% agarose gel electrophoresis was used to preliminarily detect whether the PCR product contained the target fragment band. After recovery and detection, the recombinant plasmids containing the target fragment after enzyme digestion and identification were randomly selected for DNA sequence determination. The sequencing work was completed by Shanghai Yingjun Biotechnology Co., Ltd., using the American ABI377 sequence analyzer. The sequencing result and the cDNA fragment sequence were spliced and analyzed to determine whether it was the 3' extension of the cDNA fragment sequence. the
同样利用已知的cDNA片段序列,在靠近其5′末端的位置设计一对引物,5′-RACE 1st Primer:CGAGCCGAACATTGGCATCAG;如SEQ ID NO:8所示;3′-RACE 2nd Primer:TAGAACACCAGAGCCTTGGA;如SEQ ID NO:9所示。采用5′端加接头的方法进行,经回收、检测,随机选送酶切鉴定后含目的片段的重组质粒进行DNA序列测定。测序工作交由上海英骏生物技术有限公司完成。把测序结果与cDNA 片段的序列进行拼接分析,判断其是否是cDNA片段序列5′的延伸。 Also use the known cDNA fragment sequence to design a pair of primers near its 5' end, 5'-RACE 1st Primer: CGAGCCGAACATTGGCATCAG; as shown in SEQ ID NO: 8; 3'-RACE 2nd Primer: TAGAACACCAGAGCCTTGGA; Shown in SEQ ID NO:9. The method of adding a linker at the 5' end is used. After recovery and detection, the recombinant plasmid containing the target fragment after identification by enzyme digestion is randomly selected for DNA sequence determination. The sequencing work was completed by Shanghai Yingjun Biotechnology Co., Ltd. The sequencing results and the sequence of the cDNA fragment were spliced and analyzed to determine whether it was a 5′ extension of the cDNA fragment sequence. the
对所得到的片段序列、3′和5′序列进行Blast分析后,利用DNAstar软件包的SeqMan 程序将三个片段进行比对拼接,拼接所得序列即为萜类合成酶基因cDNA全长序列。拼接所得的cDNA全长序列再在NCBI上对核苷酸序列及推导的蛋白质序列进行同源性比较和分析。 After performing Blast analysis on the obtained fragment sequences, 3′ and 5′ sequences, the three fragments were compared and spliced using the SeqMan program of the DNAstar software package, and the spliced sequence was the full-length cDNA sequence of the terpene synthase gene. The full-length cDNA sequence obtained by splicing was compared and analyzed for homology of nucleotide sequence and deduced protein sequence on NCBI. the
基因cDNA全长序列的获得: Obtaining the full-length sequence of gene cDNA:
根据已经得到的基因cDNA全长,设计并合成上下游引物,Hctps1-P1:ATGGCATCATCCCTCACTTTCTC;如SEQ ID NO:10所示。Hctps1-P2:CTA GAGGGCAGAAGCAATAAAC;如SEQ ID NO:11所示。以百合cDNA为模板,采用TaKaRa PCR Amplification Kit进行PCR扩增反应。反应条件为:94℃预变性4min;94℃变性30s、复性30s(温度视具体而定)、72℃延伸3min,35个循环;然后72℃总延伸10min。取5μLPCR产物在含溴化乙锭0.8%的琼脂糖凝胶中进行电泳鉴定,紫外光下观察实验结果。 According to the obtained full-length gene cDNA, design and synthesize upstream and downstream primers, Hctps1-P1: ATGGCATCATCCCTCACTTTCTC; as shown in SEQ ID NO:10. Hctps1-P2: CTA GAGGGCAGAAGCAATAAAC; shown in SEQ ID NO:11. Using lily cDNA as a template, the PCR amplification reaction was carried out using TaKaRa PCR Amplification Kit. The reaction conditions are: pre-denaturation at 94°C for 4 minutes; denaturation at 94°C for 30 s, renaturation for 30 s (depending on the temperature), extension at 72°C for 3 min, 35 cycles; and a total extension at 72°C for 10 min. Take 5 μL of PCR products for identification by electrophoresis in agarose gel containing 0.8% ethidium bromide, and observe the experimental results under ultraviolet light.
应用Agarose Gel DNA Purification Kit Ver. 2.0(TaKaRa),按照操作说明,将PCR 产物纯化回收,回收产物溶解于25μLElution Buffer中。取纯化回收产物4μL、pMD20-T Vector 1μL、连接液Solution I 5μL,组成10μL的连接体系,16℃下连接过夜。转化大肠杆菌菌株DH5α感受态细胞,涂布于含有X-gal、IPTG、氨苄青霉素的LB固体培养基上,37℃培养过夜;然后挑选白色克隆斑20个于含有氨苄青霉素的LB液体培养基中,37℃、240rpm扩大培养16-24h;用质粒DNA小抽试剂盒(上海博亚生物有限公司)提取质粒,琼脂糖凝胶电泳比较质粒大小并将明显滞后的质粒进行酶切鉴定。从鉴定出的阳性重组质粒中随机挑选,送上海英骏生物技术有限公司进行序列测定。获得LoAAT1基因的全长cDNA序列和全长DNA序列,根据cDNA序列推测出其蛋白序列。 Using Agarose Gel DNA Purification Kit Ver. 2.0 (TaKaRa), according to the operating instructions, the PCR product was purified and recovered, and the recovered product was dissolved in 25 μL Lution Buffer. Take 4 μL of purified recovered product, 1 μL of pMD20-T Vector, and 5 μL of linker Solution I to form a 10 μL connection system, and connect overnight at 16°C. Transform Escherichia coli strain DH5α competent cells, spread on LB solid medium containing X-gal, IPTG, and ampicillin, and culture overnight at 37°C; then pick 20 white clonal spots and put them in LB liquid medium containing ampicillin , 37°C, 240rpm expanded culture for 16-24h; use the plasmid DNA mini-prep kit (Shanghai Boya Biological Co., Ltd.) to extract the plasmid, compare the size of the plasmid by agarose gel electrophoresis, and carry out enzyme digestion identification of the obviously lagging plasmid. Select randomly from the identified positive recombinant plasmids and send them to Shanghai Yingjun Biotechnology Co., Ltd. for sequence determination. The full-length cDNA sequence and full-length DNA sequence of LoAAT1 gene were obtained, and its protein sequence was deduced according to the cDNA sequence.
实施例2 LoAAT1基因的表达分析: Example 2 Expression analysis of LoAAT1 gene:
不同品种百合花瓣,西伯利亚百合不同发育时期花瓣及西伯利亚百合不同组织部位的RNA提取使用Trizol法(TaKaRa),荧光定量PCR采用SYBR green(TaRaKa)法,染料法的具体原理见说明书。利用Primer Premier 5.0软件设计实时荧光定量PCR引物,按荧光定量PCR引物设计原则,用Primer premier 5.0分别设计引物,通过荧光定量PCR检测其是否有错配或引物二聚体及其扩增效率,从中选择一对最佳引物,P1:ATTGTGGTGCCAGTTTGCTTGC;如SEQ ID NO:12所示。P2:CCCTTTTACCCTTCGTTGAACTTC;如SEQ ID NO:13所示。内参基因ACT根据Real-time PCR引物的设计原则,用Primer premier 5.0设计引物,ACT-P1:TTCGTGTTGCACCAGAAGAGC,如SEQ ID NO:14所示,ACT-P2:TGAATGGCGACATACATGGCAG;如SEQ ID NO:15所示。通过Real-time PCR进行检测,并制作标准曲线,以检测其扩增效率(E)是否在90~110%范围内进行筛选。以各样品的cDNA为模板,在ABI荧光定量PCR仪上进行荧光定量PCR反应。每个样品设3个重复,以ddH2O为阴性对照。反应体系为SYBR Premix Ex Taq(TaKa Ra)10.0 μL,上游引物(10 μM)0.4 μL,下游引物(10 μM)0.4 μL, cDNA 2.0 μL,ddH2O 7.2μL。反应程序为94℃,30 s;94℃,15 s;55℃,30 s;72℃,30 min;40个循环,94℃ 15 s,72℃ 30 s, 0.4℃/s 融解曲线分析。反应结束后确认扩增曲线和融解曲线,用2-△△Ct法(2(-Delta Delta C(T)),Livak and Schmittgen,2001)进行数据分析,计算百合LoAAT1在不同样品中的表达情况。基因表达分析结果见图1和图2。从图1和图2中可以看出: Trizol method (TaKaRa) was used for RNA extraction of lily petals of different varieties, petals of different developmental stages of Siberia lily and different tissue parts of Siberia lily, and SYBR green (TaRaKa) method for fluorescence quantitative PCR. The specific principle of dye method is shown in the instruction manual. Using Primer Premier 5.0 software to design real-time fluorescent quantitative PCR primers, according to the principles of fluorescent quantitative PCR primer design, use Primer premier 5.0 to design primers respectively, and detect whether there are mismatches or primer dimers and their amplification efficiency by fluorescent quantitative PCR. Select a pair of optimal primers, P1: ATTGTGGTGCCAGTTTGCTTGC; as shown in SEQ ID NO:12. P2: CCCTTTTACCCTTCGTTGAACTTC; shown in SEQ ID NO:13. The internal reference gene ACT was designed with Primer premier 5.0 according to the design principles of Real-time PCR primers, ACT-P1: TTCGTGTTGCACCAGAAGAGC, as shown in SEQ ID NO:14, ACT-P2: TGAATGGCGACATACATGGCAG; as shown in SEQ ID NO:15. Detect by Real-time PCR, and make a standard curve to test whether the amplification efficiency (E) is within the range of 90-110%. Using the cDNA of each sample as a template, a fluorescent quantitative PCR reaction was performed on an ABI fluorescent quantitative PCR instrument. Three replicates were set up for each sample, and ddH 2 O was used as a negative control. The reaction system was SYBR Premix Ex Taq (TaKa Ra) 10.0 μL, upstream primer (10 μM) 0.4 μL, downstream primer (10 μM) 0.4 μL, cDNA 2.0 μL, ddH 2 O 7.2 μL. The reaction program was 94°C, 30 s; 94°C, 15 s; 55°C, 30 s; 72°C, 30 min; 40 cycles, 94°C 15 s, 72°C 30 s, 0.4°C/s melting curve analysis. After the reaction, confirm the amplification curve and melting curve, and use the 2- △△Ct method (2(-Delta Delta C(T)), Livak and Schmittgen, 2001) for data analysis, and calculate the expression of Lily LoAAT1 in different samples . The results of gene expression analysis are shown in Figure 1 and Figure 2. It can be seen from Figure 1 and Figure 2 that:
LoAAT1仅在有花香主成分苯甲酸乙酯释放的百合品种花瓣中表达,没有改成分释放的品种中不表达,且表达量与花香释放量成显著正相关;LoAAT1仅在百合花器官中表达,在根、茎和叶等营养器官不表达,该基因的表达量与不同开花时期成显著正相关,苯甲酸乙酯释放量最多盛花期花瓣LoAAT1表达量最高,而不香的蕾期则不表达,说明LoAAT1是控制百合花香主成分苯甲酸乙酯合成释放的关键基因。 LoAAT1 is only expressed in the petals of lily cultivars that release the main component of floral fragrance, ethyl benzoate, but not in the cultivars that do not release the modified component, and the expression level is significantly positively correlated with the release of floral fragrance; LoAAT1 is only expressed in the organs of lily , is not expressed in vegetative organs such as roots, stems and leaves. The expression of this gene is significantly positively correlated with different flowering stages, and the amount of ethyl benzoate released is the highest in flower petals. expression, indicating that LoAAT1 is the key gene controlling the synthesis and release of ethyl benzoate, the main component of lily fragrance.
实施例3 Hctps1基因原核表达: Example 3 Hctps1 gene prokaryotic expression:
S1.根据所得到LoAAT1基因的cDNA全长,用包含BamHI和NotⅠ酶切位点的特异引物进行PCR扩增。PCR产物用Takara回收试剂盒回收,回收产物直接用BamHI和NotI限制性内切酶进行双酶切,1%琼脂糖凝胶回收目的片段。pET-28a原核表达载体用BamHI和NotI限制酶进行双酶切1%琼脂糖凝胶回收大片段。于16℃连接过夜,将连接产物转化大肠杆菌(E. coli)DH5α感受态细胞;提取质粒经酶切和测序鉴定后,获得重组原核表达载体。 S1. According to the obtained full-length cDNA of LoAAT1 gene, perform PCR amplification with specific primers containing Bam HI and Not Ⅰ restriction sites. The PCR product was recovered with the Takara recovery kit, and the recovered product was directly digested with BamHI and NotI restriction endonucleases, and the target fragment was recovered on 1% agarose gel. The pET-28a prokaryotic expression vector was double-digested with BamHI and NotI restriction enzymes to recover large fragments on 1% agarose gel. After ligation at 16°C overnight, the ligation product was transformed into Escherichia coli ( E. coli ) DH5α competent cells; the recombinant prokaryotic expression vector was obtained after the extracted plasmid was identified by enzyme digestion and sequencing.
S2.用经鉴定的重组质粒DNA转化大肠杆菌(Rosetta)感受态细胞,挑取单菌落接种于5mL LB(含25 mg /L Kan,34 mg /L Chl)培养基中,37℃震荡培养过夜。转接100 μL种子液于新鲜的100ml(含25 mg /L Kan,34 mg /L Chl)的LB培养基中,37℃180rpm培养4~6h,测OD值至0.4~0.6后用一定量的IPTG(0.1~0.2mM)在14~18℃诱导14~16h。同时取另一对照组其中未加IPTG诱导。离心收集菌体,用5ml裂解buffer (50mM磷酸buffer pH 8.0)悬浮细胞,将菌体冷却,置于冰上超声波破碎细胞。12000rpm,4℃离心10min,将上清移至新的离心管中,用双蒸水清洗沉淀一次,再用5mL裂解buffer悬浮沉淀。分别取上清和沉淀各50 μL,保存与-20℃,进行SDS-PAGE电泳分析。配制12.5% SDS聚丙烯酰胺凝胶,按照顺序上样。分别用60V和120V的电压对浓缩胶和分离胶的进行电泳。电泳完毕,考马斯亮蓝染色30min,再用脱色液脱色1~8h,观察并记录试验结果。 S2. Transform Escherichia coli (Rosetta) competent cells with the identified recombinant plasmid DNA, pick a single colony and inoculate it in 5 mL LB (containing 25 mg/L Kan, 34 mg/L Chl) medium, and culture overnight at 37°C with shaking . Transfer 100 μL seed solution to fresh 100ml (containing 25 mg/L Kan, 34 mg/L Chl) LB medium, culture at 180 rpm at 37°C for 4-6 hours, measure the OD value to 0.4-0.6 and use a certain amount of IPTG (0.1-0.2mM) was induced at 14-18°C for 14-16h. At the same time, another control group was taken which was not induced by IPTG. Collect the cells by centrifugation, suspend the cells with 5ml lysis buffer (50mM phosphoric acid buffer pH 8.0), cool the cells, and place them on ice to sonicate the cells. Centrifuge at 12,000 rpm at 4°C for 10 min, transfer the supernatant to a new centrifuge tube, wash the precipitate once with double distilled water, and then suspend the precipitate with 5 mL of lysis buffer. Take 50 μL of supernatant and precipitate respectively, store at -20°C, and conduct SDS-PAGE electrophoresis analysis. Prepare 12.5% SDS polyacrylamide gel and load samples in order. Electrophoresis was performed on the stacking gel and the separating gel with voltages of 60V and 120V, respectively. After electrophoresis, stain with Coomassie Brilliant Blue for 30 minutes, then decolorize with decolorizing solution for 1-8 hours, observe and record the test results. the
S3.蛋白的纯化:挑取单菌落接种于5ml的液体LB培养基中,37℃,180rpm,培养过夜,后全部转接至500mL的新鲜液体LB培养集中,37℃,180rpm,培养4h,用IPTG(0.1~0.2 mM),18℃条件下诱导16h后,收集菌体。取200μL菌体于离心管中,4℃保存,进行SDS-PAGE电泳分析。用5mL的裂解buffer悬浮细胞并转移至离心管内,置于冰上使菌体始终保持冷却,超声波破碎细胞。10,000 x g,4℃离心20~30 min,收集上清液。取20 μL的上清于-20℃保存,进行SDS-PAGE分析。向5mL细胞裂解液中加入1~2mL的Ni-NTA resin(镍--次氮基三乙酸树脂填料)混匀,并低速在4℃ 摇床上结合60min。将结合完全的细胞裂解液和树脂混合物装入层析柱中,移走底部盖帽收集流出液部分(flow-through fraction,F),取20μL的流出液,于-20℃保存,进行SDS-PAGE分析。用4ml的洗涤buffer洗脱层析柱两次,收集每部分的洗脱液(wash fraction, W),各取20 μL保存于-20℃冰箱中作SDS-PAGE分析。用0.5mL的洗脱buffer 洗柱四次,分别用不同的收集管依次收集每部分的洗脱液(elution fraction,E),分别标记为E1, E2, E3, E4,各取20μL进行SDS-PAGE 分析。根据SDS-PAGE的检测结果,集中含有目标蛋白洗脱部分于一个离心管中,用移液器转移至透析袋中,4℃透析过夜。收集透析后的溶液,加入甘油使蛋白溶液中甘油总含量为20%,并且以200 μL /管的量进行分装,取微量进行SDS-PAGE蛋白浓度检测,其余的放于-70℃超低温冰箱进行保存备用。 S3. Purification of protein: Pick a single colony and inoculate it in 5ml of liquid LB medium, cultivate overnight at 37°C, 180rpm, then transfer all of them to 500mL of fresh liquid LB culture medium, cultivate for 4h at 37°C, 180rpm, and use After induction with IPTG (0.1-0.2 mM) at 18°C for 16 hours, the cells were collected. Take 200 μL of bacteria in a centrifuge tube, store at 4°C, and perform SDS-PAGE electrophoresis analysis. Suspend the cells with 5 mL of lysis buffer and transfer to a centrifuge tube, place on ice to keep the cells cool, and disrupt the cells by ultrasonic. Centrifuge at 10,000 x g for 20-30 min at 4°C, and collect the supernatant. Take 20 μL of the supernatant and store it at -20°C for SDS-PAGE analysis. Add 1-2 mL of Ni-NTA resin (nickel-nitrilotriacetic acid resin filler) to 5 mL of cell lysate, mix well, and combine on a shaker at 4 °C for 60 min at low speed. Put the fully combined cell lysate and resin mixture into the chromatography column, remove the bottom cap to collect the effluent fraction (flow-through fraction, F), take 20 μL of the effluent, store it at -20°C, and perform SDS-PAGE analyze. Use 4ml of washing buffer to elute the chromatography column twice, collect each fraction of the eluate (wash fraction, W), and take 20 μL each and store it in a -20°C refrigerator for SDS-PAGE analysis. Wash the column four times with 0.5mL of elution buffer, collect each part of the eluent (elution fraction, E) sequentially with different collection tubes, respectively marked as E1, E2, E3, E4, and take 20 μL each for SDS- PAGE analysis. According to the detection results of SDS-PAGE, concentrate the eluted fraction containing the target protein into a centrifuge tube, transfer it to a dialysis bag with a pipette, and dialyze overnight at 4°C. Collect the solution after dialysis, add glycerol to make the total glycerol content in the protein solution 20%, and divide it into 200 μL/tube, take a small amount for SDS-PAGE protein concentration detection, and store the rest in a -70°C ultra-low temperature refrigerator Save for backup. the
S4.醇酰基合成酶酶活性鉴定:转接100 μL种子液于新鲜的200mL(含25 mg /L Kan,34 mg /L Chl)的LB培养基中,37℃180rpm培养4~6h,测OD值至0.4~0.6后用一定量的IPTG(0.1~0.2mM)在14~18℃诱导14~16h。5000rpm,4℃离心5min离心收集菌体,用5mLbuffer (10mM MOPS buffer pH 7.0 10%甘油 1mM DTT)悬浮细胞,置于冰上超声波破碎细胞。12000rpm,4℃离心20min,将上清移至新的离心管中。 S4. Identification of alcohol acyl synthetase enzyme activity: Transfer 100 μL of seed solution to fresh 200 mL (containing 25 mg/L Kan, 34 mg/L Chl) LB medium, culture at 37°C and 180 rpm for 4-6 hours, and measure OD After the value reaches 0.4-0.6, a certain amount of IPTG (0.1-0.2mM) is used to induce at 14-18°C for 14-16h. Centrifuge at 5000rpm at 4°C for 5min to collect the cells, suspend the cells with 5mL buffer (10mM MOPS buffer pH 7.0 10% glycerol 1mM DTT), and place on ice to sonicate the cells. Centrifuge at 12000rpm at 4°C for 20min, and transfer the supernatant to a new centrifuge tube. the
S5.酶促反应及GC-MS分析: 将80 μL 50μM pH 8.0Tris-HCl,酶提取液50μL,0.05μM苯甲酰CoA 20μL溶液,5.8 μL 20μm的乙醇溶液,巯基乙醇溶液2 μL和ddH2O 842.2 μL加入样品瓶中密封,将75μm 聚二甲基氧烷(PMDS)萃取纤维头插入玻璃瓶中,28℃水浴1h,顶空固相微萃取,反应结束后将萃取纤维头放至气相色谱-质谱连用仪中进行分析,气相色谱条件为:色谱柱为HP-1NNOWAX柱(30m×0.25mm) ;载气为高纯氦气,分流比20:1,柱前压50 Pa,流量1 mL /min;取样时间2min;程序升温:柱起始温度45 ℃,保持2min,以5 ℃/min的速度升至80 ℃保持1min,然后以10℃/min的速度升至250℃保持5 min。质谱条件为:GC-MS 的接口温度220 ℃,电子轰击源EI、350V;离子源温度170 ℃;电子能量70 eV;扫描质量范围35~335aum,采集到的质谱图用WILLEY/MAINLIB库进行分析。原核表达结果见图3。从图3中可以看出:以乙醇和苯甲酰CoA为底物的pET-28a- Lo-AAT1体外酶催化反应产物经质谱鉴定为苯甲酸乙酯,与采用苯甲酸乙酯标样色谱和质谱图相一致,说明该基因编码生成的酶是一种以乙醇与苯甲酰CoA为底物合成苯甲酸乙酯的酶,该基因为乙醇苯甲酰基转移酶基因。 S5. Enzymatic reaction and GC-MS analysis: Mix 80 μL of 50 μM Tris-HCl pH 8.0, 50 μL of enzyme extract, 20 μL of 0.05 μM benzoyl-CoA solution, 5.8 μL of 20 μM ethanol solution, 2 μL of mercaptoethanol solution and ddH 2 O 842.2 μL was added to the sample bottle and sealed, and the 75 μm polydimethyloxane (PMDS) extraction fiber head was inserted into the glass bottle, and the 28 ° C water bath was performed for 1 hour, and the headspace solid phase microextraction was performed. After the reaction, the extraction fiber head was placed in the gas phase Chromatography-mass spectrometry was used for analysis, and the gas chromatography conditions were as follows: the chromatographic column was HP-1NNOWAX column (30m×0.25mm); the carrier gas was high-purity helium, the split ratio was 20:1, the pre-column pressure was 50 Pa, and the flow rate was 1 mL /min; sampling time 2min; temperature program: the initial column temperature is 45°C, keep for 2min, increase to 80°C at a speed of 5°C/min, hold for 1min, then rise to 250°C at a speed of 10°C/min, and hold for 5 minutes . The mass spectrometry conditions are: GC-MS interface temperature 220 °C, electron bombardment source EI, 350V; ion source temperature 170 °C; electron energy 70 eV; scanning mass range 35-335 aum, and the collected mass spectra were analyzed with the WILLEY/MAINLIB library . The prokaryotic expression results are shown in Figure 3. As can be seen from Figure 3: the pET-28a-Lo-AAT1 in vitro enzyme-catalyzed reaction product with ethanol and benzoyl-CoA as the substrate was identified as ethyl benzoate by mass spectrometry, and was compared with ethyl benzoate standard sample chromatography and The mass spectrograms are consistent, indicating that the gene encoded by the gene is an enzyme that synthesizes ethyl benzoate with ethanol and benzoyl-CoA as substrates, and the gene is an ethanol benzoyltransferase gene.
实施例4 LoAAT1对烟草的遗传转化: Embodiment 4 LoAAT1 genetic transformation of tobacco:
S1.载体构建及农杆菌转化:将LoAAT1基因的全长cDNA序列用EcoRI和BamHI酶切,回收目的片段;载体pMOGMON用EcoRI和BamHI酶切,纯化回收相应大小的片段,连接,转化DH5α,提质粒,酶切鉴定,挑出所需克隆,测序,并将其转化到农杆菌LBA4404中。 S1. Vector construction and Agrobacterium transformation: the full-length cDNA sequence of the LoAAT1 gene was digested with Eco RI and Bam HI, and the target fragment was recovered; the vector pMOGMON was digested with Eco RI and Bam HI, purified and recovered fragments of corresponding size, ligated, Transform DH5α, extract the plasmid, identify by enzyme digestion, pick out the desired clone, sequence it, and transform it into Agrobacterium LBA4404.
S2.烟草转化:将烟草“W38” 叶片(0.5 cm×0.5 cm 的方块)在培养基中预培养2~3 d,用步骤S1得到的OD600 0.5~0.8的农杆菌LBA4404菌液,浸染5~10min,然后共培养3 d,烟草在含有20 mg/L潮霉素Hyg 、400 mg/L头孢霉素Cef的培养基上 ,矮牵牛在含有5 mg/L潮霉素Hyg 、400 mg/L头孢霉素Cef 的培养基上,在光照 2000~10000Lx,25 ℃条件下进行选择培养。选择培养 2~3 周后,外植体的转化细胞将产生抗性愈伤组织,将材料转入相应的选择分化培养基中进行分化出芽培养,待不定芽长至1 cm 以上时,切下并插入含有选择压的生根培养基上进行生根培养,每瓶插入2~3棵小苗,进行生根诱导。将根长至约4~5 cm健壮小苗,炼苗5~6d,炼苗结束后,清水洗净根部培养基,进行移栽。 S2. Tobacco transformation: Pre-cultivate tobacco “W38” leaves (0.5 cm×0.5 cm square) in the culture medium for 2-3 days, use the Agrobacterium LBA4404 bacterial solution with OD 600 of 0.5-0.8 obtained in step S1, and dip for 5 ~10min, and then co-cultivated for 3 days. Tobacco was on a medium containing 20 mg/L hygromycin Hyg and 400 mg/L cephalosporin Cef, and petunia was on a medium containing 5 mg/L hygromycin Hyg and 400 mg /L cephalosporin Cef culture medium, under the conditions of 2000-10000Lx light and 25°C for selection culture. After 2 to 3 weeks of selective culture, the transformed cells of the explants will produce resistant callus, and the material is transferred to the corresponding selective differentiation medium for differentiation and budding culture. When the adventitious bud grows to more than 1 cm, cut off And insert it into the rooting medium containing selective pressure for rooting culture, insert 2 to 3 seedlings in each bottle, and carry out rooting induction. The roots grow to about 4-5 cm and the seedlings are strong and strong, and the seedlings are hardened for 5-6 days. After the hardening is completed, the root medium is washed with clean water, and then transplanted.
S3.转基因烟草基因组DNA的提取: S3. Extraction of genetically modified tobacco genomic DNA:
S31.取0.2 g材料,加入液氮研磨成粉末,将磨好的材料转入2 ml的离心管中,加入1 ml 预热2 % CTAB 提取液(含0.1%的巯基乙醇),充分混匀,置于65℃水浴45 min,6~8min混匀一次。10000 rpm,离心5 min。 S31. Take 0.2 g of material, add liquid nitrogen and grind it into powder, transfer the ground material into a 2 ml centrifuge tube, add 1 ml of preheated 2 % CTAB extract (containing 0.1% mercaptoethanol), and mix well , placed in a 65°C water bath for 45 minutes, and mixed once every 6-8 minutes. Centrifuge at 10000 rpm for 5 min.
S32.冷至室温,取上清液,加入等体积的氯仿/异戊醇(24:1),轻轻混匀至溶液成乳化状,10000 rpm,离心5 min。 S32. Cool to room temperature, take the supernatant, add an equal volume of chloroform/isoamyl alcohol (24:1), mix gently until the solution becomes emulsified, and centrifuge at 10,000 rpm for 5 min. the
S33.取上清,加入2/3体积预冷的异丙醇,-20℃放置30min。10000 rpm离心5 min,弃上清液,用70%乙醇洗涤沉淀2~3次。加入200 μl TE溶液溶解。 S33. Take the supernatant, add 2/3 volume of pre-cooled isopropanol, and place it at -20°C for 30 minutes. Centrifuge at 10,000 rpm for 5 min, discard the supernatant, and wash the precipitate with 70% ethanol for 2 to 3 times. Add 200 μl TE solution to dissolve. the
S34.加入1/10体积NaAC(3 mol/L)和2倍体积的无水乙醇,-20℃放置2h以上。12000 rpm离心5min,弃上清液,沉淀用70%乙醇洗涤2~3次,室温干燥沉淀。用20~50 μL1×TE溶解,-20℃保存。 S34. Add 1/10 volume of NaAC (3 mol/L) and 2 volumes of absolute ethanol, and place at -20°C for more than 2 hours. Centrifuge at 12000 rpm for 5 min, discard the supernatant, wash the precipitate with 70% ethanol for 2 to 3 times, and dry the precipitate at room temperature. Dissolve with 20-50 μL 1×TE and store at -20°C. the
S4.转基因烟草PCR检测:以转化菌液为阳性对照,未转化DNA作阴性对照,进行PCR扩增体系。S4. PCR detection of transgenic tobacco: The transformed bacterial liquid was used as a positive control, and the untransformed DNA was used as a negative control, and the PCR amplification system was carried out.
上游引物F2:CTT CTA CAC AGC CAT CGG TCC AGA;如SEQ ID NO:16所示。 Upstream primer F2: CTT CTA CAC AGC CAT CGG TCC AGA; as shown in SEQ ID NO:16. the
下游引物R2:GAT GTA GGA GGG CGT GGA TAT GTC; 如SEQ ID NO:17所示。 Downstream primer R2: GAT GTA GGA GGG CGT GGA TAT GTC; as shown in SEQ ID NO:17. the
反应体系(20μL):转基因植株DNA 1μL(20ng~50ng);10×buffer 2μL;MgCl2(2.5mM) 2μL;Taq酶 0.2μL; dNTP(2.5mM) 2μL;引物各加10μM;加无菌水至25μL。 Reaction system (20μL): transgenic plant DNA 1μL (20ng~50ng); 10×buffer 2μL; MgCl 2 (2.5mM) 2μL; Taq enzyme 0.2μL; dNTP (2.5mM) 2μL; to 25 μL.
反应条件:94℃,4分钟;94℃,30秒;54℃,30秒;72℃,1分钟;30个循环;72℃延伸10分钟。筛选出PCR阳性植株(图4)。 Reaction conditions: 94°C, 4 minutes; 94°C, 30 seconds; 54°C, 30 seconds; 72°C, 1 minute; 30 cycles; 72°C extension for 10 minutes. PCR-positive plants were screened out (Figure 4). the
S5.转基因烟草植株挥发性物质SPME-GC/MS分析:采用固相微萃取-气相色谱质谱方法分析。将烟草小苗从基质中取出,洗净,置于2.5 L密封箱中,加入31.6 ng/μL(100 μM SNP处理为316 ng/μL)的癸酸乙酯10 μL作为内标物,用聚四氟乙烯衬里的硅橡胶垫密封,插入100 μm聚二甲基硅氧烷(PMDS)萃取纤维头,于25℃ 温下顶空取样30 min。采用FINNIGAN TRACE MS气质联用仪(美国)进行分析。色谱条件为DB-5石英毛细管柱长30 m,内径0.25 mm,液膜厚0.25 μm,载气He,柱头压力68.974 kPa,程序分流/不分流(LSS)进样口温度250℃。程序升温:50℃,保持2 min;以3℃/min的升温速度升至250℃,保持30 min。在SPME分析中,PSS进样口设定为不分流进样方式,不分流时间为2 min,衬管采用1.5 mm内径的玻璃管,脱附时间为3 min;在DHS进样口分流比为20:1,进样量为2.0 μL。GC/MS传输线温度为250℃,质量扫描范围是30~350 aμm,扫描时间0.3 s,扫描间隔0.2 s,EI离子源温度170℃,EI电子能量70 eV,光电倍增管(PMT)电压230 V,对采集到的质谱图用WILEY、MAINLIB、REPLIB及NISTDEMO 4个库进行分析,并根据各组分峰面积与内标癸酸乙酯峰面积之比定量,确定烟草挥发性物质的化学成分。结果表明:野生型烟草中主要的挥发物是乙酸叶醇酯和叶醇,含量分别为0.241 μg/gFW.h和0.263 μg/gFW.h;而转基因植株中有苯甲酸甲酯、苯甲酸乙酯和2-羟基苯甲酸甲酯,它们挥发量分别是0.020 μg/gFW.h、0.349 μg/gFW.h和0.044 μg/gFW.h,其中苯甲酸乙酯是主要的挥发成分。这说明醇酰基转移酶基因LoAAT1在烟草中正义表达改变了烟草叶片挥发性成分的组成,苯甲酸乙酯挥发量有较大提高。 S5. SPME-GC/MS analysis of volatile substances in transgenic tobacco plants: analysis by solid-phase microextraction-gas chromatography-mass spectrometry. Tobacco seedlings were taken out from the substrate, washed, and placed in a 2.5 L sealed box, and 10 μL of 31.6 ng/μL (100 μM SNP treatment was 316 ng/μL) ethyl caprate was added as an internal standard, and polytetrafluoroethylene Fluorine-lined silicone rubber gasket was sealed, and a 100 μm polydimethylsiloxane (PMDS) extraction fiber head was inserted, and headspace sampling was carried out at 25 °C for 30 min. Using FINNIGAN TRACE MS mass spectrometer (USA) for analysis. The chromatographic conditions were a DB-5 quartz capillary column with a length of 30 m, an inner diameter of 0.25 mm, a liquid film thickness of 0.25 μm, a carrier gas of He, a column head pressure of 68.974 kPa, and a programmed split/splitless (LSS) inlet temperature of 250 °C. Programmed temperature rise: 50°C, keep for 2 min; increase to 250°C at a rate of 3°C/min, keep for 30 min. In the SPME analysis, the PSS inlet was set as splitless injection, the splitless time was 2 min, the liner was a glass tube with an inner diameter of 1.5 mm, and the desorption time was 3 min; in the DHS inlet, the split ratio was 20:1, the injection volume is 2.0 μL. The temperature of the GC/MS transmission line is 250°C, the mass scanning range is 30-350 aμm, the scan time is 0.3 s, the scan interval is 0.2 s, the EI ion source temperature is 170°C, the EI electron energy is 70 eV, and the photomultiplier tube (PMT) voltage is 230 V , the collected mass spectra were analyzed with WILEY, MAINLIB, REPLIB and NISTDEMO, and the chemical components of tobacco volatile substances were determined according to the ratio of the peak area of each component to the peak area of the internal standard ethyl caprate. The results showed that the main volatiles in wild-type tobacco were leaf alcohol acetate and leaf alcohol, the contents were 0.241 μg/gFW.h and 0.263 μg/gFW.h; Esters and methyl 2-hydroxybenzoate, their volatile amounts are 0.020 μg/gFW.h, 0.349 μg/gFW.h and 0.044 μg/gFW.h, respectively, and ethyl benzoate is the main volatile component. This shows that positive expression of alcohol acyltransferase gene LoAAT1 in tobacco changes the composition of volatile components in tobacco leaves, and the volatilization of ethyl benzoate is greatly increased.
SEQUENCE LISTING SEQUENCE LISTING
the
<110> 华南农业大学 <110> South China Agricultural University
the
<120> 一种百合酯类花香基因LoAAT1及其应用 <120> A lily ester floral fragrance gene LoAAT1 and its application
the
<130> <130>
the
<160> 17 <160> 17
the
<170> PatentIn version 3.3 <170> PatentIn version 3.3
the
<210> 1 <210> 1
<211> 1380 <211> 1380
<212> DNA <212> DNA
<213> LoAAT1基因全长cDNA序列 <213> LoAAT1 gene full-length cDNA sequence
the
<400> 1 <400> 1
atggcatcat ccctcacttt ctctgtccaa agccgccagc ccgagctcat cgcaccggca 60 atggcatcat ccctcacttt ctctgtccaa agccgccagc ccgagctcat cgcaccggca 60
the
gccccgaccc cccacgagct caagcgcctc tccgacattg acgaccaaga gggtctccgg 120 gccccgaccc cccacgagct caagcgcctc tccgacattg acgaccaaga gggtctccgg 120
the
ttccagatac cggtcatcca attctaccgc cacgaccctt tactaggcgg tgcaagagac 180 ttccagatac cggtcatcca attctaccgc cacgaccctt tactaggcgg tgcaagagac 180
the
cctgtgatgg ttatccgaga ggcacttgct aaggctctgg tgttttacta ccccttggcc 240 cctgtgatgg ttatccgaga ggcacttgct aaggctctgg tgttttacta ccccttggcc 240
the
ggccgcctca gggagggggc tgaccgcaag ctcgcggtgg agtgcactgg tgagggtgtt 300 ggccgcctca gggaggggggc tgaccgcaag ctcgcggtgg agtgcactgg tgagggtgtt 300
the
gttttcatcg aggctgatgc caatgttcgg ctcgaacagt ttggtgatgc tctgcagccg 360 gttttcatcg aggctgatgc caatgttcgg ctcgaacagt ttggtgatgc tctgcagccg 360
the
cctttcccat gcctggagga gttgctcttc gacgttgagg gctccagcgg gatactcggc 420 cctttcccat gcctggagga gttgctcttc gacgttgagg gctccagcgg gatactcggc 420
the
tgcccgctga tcctaattca ggtgactcgc ttgagttgcg gtggcttcat ctttgccctc 480 tgcccgctga tcctaattca ggtgactcgc ttgagttgcg gtggcttcat ctttgccctc 480
the
cgtctcaacc acaccatctc ggacgctgcc ggcctcgtac agttcatgac cgccgtcggc 540 cgtctcaacc accacatctc ggacgctgcc ggcctcgtac agttcatgac cgccgtcggc 540
the
gagctcgccc gtggcgcaat cgcaccaaca gtccaaccag tctgggcgcg ccacctcctc 600 gagctcgccc gtggcgcaat cgcaccaaca gtccaaccag tctgggcgcg ccacctcctc 600
the
gaggctcgct ccccgccctg ccccaccttc gcccatcgcg agtacgatgt catccctgat 660 gaggctcgct ccccgccctg ccccaccttc gcccatcgcg agtacgatgt catccctgat 660
the
acaaagaaca ccctcatccc cttggacgac atggtccacc gctcattctt tttcggtcgc 720 acaaagaaca ccctcatccc cttggacgac atggtccacc gctcattctt tttcggtcgc 720
the
cgcgagatcg ctgccttgcg tcgccgtgtc ccccaccacc tccgcagctc ctccaccttt 780 cgcgagatcg ctgccttgcg tcgccgtgtc ccccaccacc tccgcagctc ctccaccttt 780
the
gagatcctca ccgcctccct ctggaagtgt cgcacatcct ccatccaagt cgacccatac 840 gagatcctca ccgcctccct ctggaagtgt cgcacatcct ccatccaagt cgacccatac 840
the
gaagaggtcc gcatcatctg cattgtcaac tcacgcggga agttcaaccc accgctgccg 900 gaagaggtcc gcatcatctg cattgtcaac tcacgcggga agttcaaccc accgctgccg 900
the
acagggtact atgggaatgc tttagcatta cccgtggccg tggcggaggc aggaaaggtg 960 acagggtact atgggaatgc tttagcatta cccgtggccg tggcggaggc aggaaaggtg 960
the
gctaacaacc ctcttgggta cgcattggag ttggtgaaga aagcgaaggc agaggtgact 1020 gctaacaacc ctcttgggta cgcattggag ttggtgaaga aagcgaaggc agaggtgact 1020
the
gaggagtata tgaaatcggt tgctgacttg atggtaatca ggggacgacc tcacttcacg 1080 gaggagtata tgaaatcggt tgctgacttg atggtaatca ggggacgacc tcacttcacg 1080
the
gcggtgagaa cttacttggt ttcggacttg aaaagggcgg ggttcaggga tgtggatttc 1140 gcggtgagaa cttacttggt ttcggacttg aaaagggcgg ggttcaggga tgtggatttc 1140
the
ggatggggaa aggcagtata tggtggagcc gcgaagggag gggttggggt gattcccggg 1200 ggatggggaa aggcagtata tggtggagcc gcgaagggag gggttggggt gattcccggg 1200
the
gtcataagct tctttgtacc attcaagaat aggaatggag aggatgggat tgtggtgcca 1260 gtcataagct tctttgtacc attcaagaat aggaatggag aggatgggat tgtggtgcca 1260
the
gtttgcttgc caggtccagc aatggagaag tttttggtgg agattgaaag gctcacgaag 1320 gtttgcttgc caggtccagc aatggagaag tttttggtgg agattgaaag gctcacgaag 1320
the
gtgtccgaga tggaggaaga gcatggcacg aacgcgcagt ttattgcttc tgccctctag 1380 gtgtccgaga tggaggaaga gcatggcacg aacgcgcagt ttattgcttc tgccctctag 1380
the
the
<210> 2 <210> 2
<211> 1472 <211> 1472
<212> DNA <212> DNA
<213> LoAAT1基因全长DNA序列 <213> Full-length DNA sequence of LoAAT1 gene
the
<400> 2 <400> 2
atggcatcat ccctcacttt ctctgtccaa aggcgccagc ccgagctcat cgcaccggca 60 atggcatcat ccctcacttt ctctgtccaa aggcgccagc ccgagctcat cgcaccggca 60
the
gccccgaccc cccacgagct caagcgcctc tccgacattg acgaccaaga gggtctccgg 120 gccccgaccc cccacgagct caagcgcctc tccgacattg acgaccaaga gggtctccgg 120
the
ttccagatac cggtcatcca attctaccgc cacgaccctt tactaggcgg tgcaagagac 180 ttccagatac cggtcatcca attctaccgc cacgaccctt tactaggcgg tgcaagagac 180
the
cctgtgatgg ttatccgaga ggcacttgct aaggctctgg tgttttacta ccccttggcc 240 cctgtgatgg ttatccgaga ggcacttgct aaggctctgg tgttttacta ccccttggcc 240
the
ggccgcctca gggagggggc tgaccgcaag ctcgcggtgg agtgcactgg tgagggtgtt 300 ggccgcctca gggaggggggc tgaccgcaag ctcgcggtgg agtgcactgg tgagggtgtt 300
the
gttttcatcg aggctgatgc caatgttcgg ctcgaacagt ttggtgatgc tctgcagccg 360 gttttcatcg aggctgatgc caatgttcgg ctcgaacagt ttggtgatgc tctgcagccg 360
the
cctttcccat tactggagga gttgctcttc gacgttgagg gctccagcgg gatactcggc 420 cctttcccat tactggagga gttgctcttc gacgttgagg gctccagcgg gatactcggc 420
the
tgcccgctga tcctaattca ggtacctacc agatttattt accattgtga acacactgga 480 tgcccgctga tcctaattca ggtacctacc agattattt accattgtga acacactgga 480
the
tcttcatata ccatctacag tacgctaaaa actcaagcct tgttgttatg taggtgactc 540 tcttcatata ccatctacag tacgctaaaa actcaagcct tgttgttatg taggtgactc 540
the
gcttgagttg cggtggcttc atctttgccc tccgtctcaa ccacaccatc tcggacgctg 600 gcttgagttg cggtggcttc atctttgccc tccgtctcaa ccacaccatc tcggacgctg 600
the
ccggcctcgt acagttcatg acagccgtcg gcgagctcgc ccgtggcgca atcgcaccaa 660 ccggcctcgt acagttcatg acagccgtcg gcgagctcgc ccgtggcgca atcgcaccaa 660
the
cagtccaacc agtctgggcg cgccacctcc tcgaggctcg ctccccgccc tgccccacct 720 cagtccaacc agtctgggcg cgccacctcc tcgaggctcg ctccccgccc tgccccacct 720
the
tcgcccatcg cgagtacgaa gtcatccctg atacaaagaa caccctcatc cccttggacg 780 tcgcccatcg cgagtacgaa gtcatccctg atacaaagaa caccctcatc cccttggacg 780
the
acatggtcca ccgctcattc tttttcggtc gccgcgagat cgctgccttg cgtcgccgtg 840 acatggtcca ccgctcattc tttttcggtc gccgcgagat cgctgccttg cgtcgccgtg 840
the
tcccccacca cctccgcagc tcctccacct ttgagatcct caccgcctcc ctctggaagt 900 tcccccacca cctccgcagc tcctccacct ttgagatcct caccgcctcc ctctggaagt 900
the
gtcgcacatc ctccatccaa gtcgacccat acgaagaggt ccgcatcatc tgcattgtca 960 gtcgcacatc ctccatccaa gtcgacccat acgaagaggt ccgcatcatc tgcattgtca 960
the
actcacgcgg gaagttcaac ccaccgctgc cgacagggta ctatgggaat gctttagcat 1020 actcacgcgg gaagttcaac ccaccgctgc cgacagggta ctatgggaat gctttagcat 1020
the
tacccgtggc cgtggcggag gcaggaaagg tggctaacaa ccctcttggg tacgcattgg 1080 tacccgtggc cgtggcggag gcaggaaagg tggctaacaa ccctcttggg tacgcattgg 1080
the
agttggtgaa gaaagcgaag gcagaggtga cggaggagta tatgaaatcg gttgctgact 1140 agttggtgaa gaaagcgaag gcagaggtga cggaggagta tatgaaatcg gttgctgact 1140
the
tgatggtaat caggggacga cctcacttca cggcggtgag aacttacttg gtttcggact 1200 tgatggtaat caggggacga cctcacttca cggcggtgag aacttacttg gtttcggact 1200
the
tgaaaagggc ggggttcagg gatgtggatt tcggatgggg aaaggcagta tatggtggag 1260 tgaaaagggc ggggttcagg gatgtggatt tcggatgggg aaaggcagta tatggtggag 1260
the
ccgcgaaggg aggggttggg gtgattcccg gggtcataag cttctttgta ccattcaaga 1320 ccgcgaaggg aggggttggg gtgattcccg gggtcataag cttctttgta ccattcaaga 1320
the
ataggaatgg agaggatggg attgtggtgc cagtttgctt gccaggtcca gcaatggaga 1380 ataggaatgg agaggatggg attgtggtgc cagtttgctt gccaggtcca gcaatggaga 1380
the
agtttttggt ggagattgaa aggctcacga aggtgtccga gatggaggaa gagcatggca 1440 agtttttggt ggagattgaa aggctcacga aggtgtccga gatggaggaa gagcatggca 1440
the
cgaacgcgca gtttattgct tctgccctct ag 1472 cgaacgcgca gtttatgct tctgccctct ag 1472
the
the
<210> 3 <210> 3
<211> 459 <211> 459
<212> PRT <212> PRT
<213> LoAAT1编码的蛋白质序列 <213> Protein sequence encoded by LoAAT1
the
<400> 3 <400> 3
the
Met Ala Ser Ser Leu Thr Phe Ser Val Gln Ser Arg Gln Pro Glu Leu Met Ala Ser Ser Leu Thr Phe Ser Val Gln Ser Arg Gln Pro Glu Leu
1 5 10 15 1 5 10 15
the
the
Ile Ala Pro Ala Ala Pro Thr Pro His Glu Leu Lys Arg Leu Ser Asp Ile Ala Pro Ala Ala Pro Thr Pro His Glu Leu Lys Arg Leu Ser Asp
20 25 30 20 25 30
the
the
Ile Asp Asp Gln Glu Gly Leu Arg Phe Gln Ile Pro Val Ile Gln Phe Ile Asp Asp Gln Glu Gly Leu Arg Phe Gln Ile Pro Val Ile Gln Phe
35 40 45 35 40 45 45
the
the
Tyr Arg His Asp Pro Leu Leu Gly Gly Ala Arg Asp Pro Val Met Val Tyr Arg His Asp Pro Leu Leu Gly Gly Ala Arg Asp Pro Val Met Val
50 55 60 50 55 60 60
the
the
Ile Arg Glu Ala Leu Ala Lys Ala Leu Val Phe Tyr Tyr Pro Leu Ala Ile Arg Glu Ala Leu Ala Lys Ala Leu Val Phe Tyr Tyr Pro Leu Ala
65 70 75 80 65 70 75 80
the
the
Gly Arg Leu Arg Glu Gly Ala Asp Arg Lys Leu Ala Val Glu Cys Thr Gly Arg Leu Arg Glu Gly Ala Asp Arg Lys Leu Ala Val Glu Cys Thr
85 90 95 85 90 95
the
the
Gly Glu Gly Val Val Phe Ile Glu Ala Asp Ala Asn Val Arg Leu Glu Gly Glu Gly Val Val Phe Ile Glu Ala Asp Ala Asn Val Arg Leu Glu
100 105 110 100 105 110
the
the
Gln Phe Gly Asp Ala Leu Gln Pro Pro Phe Pro Cys Leu Glu Glu Leu Gln Phe Gly Asp Ala Leu Gln Pro Pro Phe Pro Cys Leu Glu Glu Leu
115 120 125 115 120 125
the
the
Leu Phe Asp Val Glu Gly Ser Ser Gly Ile Leu Gly Cys Pro Leu Ile Leu Phe Asp Val Glu Gly Ser Ser Ser Gly Ile Leu Gly Cys Pro Leu Ile
130 135 140 130 135 140
the
the
Leu Ile Gln Val Thr Arg Leu Ser Cys Gly Gly Phe Ile Phe Ala Leu Leu Ile Gln Val Thr Arg Leu Ser Cys Gly Gly Phe Ile Phe Ala Leu
145 150 155 160 145 150 155 160
the
the
Arg Leu Asn His Thr Ile Ser Asp Ala Ala Gly Leu Val Gln Phe Met Arg Leu Asn His Thr Ile Ser Asp Ala Ala Gly Leu Val Gln Phe Met
165 170 175 165 170 175
the
the
Thr Ala Val Gly Glu Leu Ala Arg Gly Ala Ile Ala Pro Thr Val Gln Thr Ala Val Gly Glu Leu Ala Arg Gly Ala Ile Ala Pro Thr Val Gln
180 185 190 180 185 190
the
the
Pro Val Trp Ala Arg His Leu Leu Glu Ala Arg Ser Pro Pro Cys Pro Pro Val Trp Ala Arg His Leu Leu Glu Ala Arg Ser Pro Pro Cys Pro
195 200 205 195 200 205
the
the
Thr Phe Ala His Arg Glu Tyr Asp Val Ile Pro Asp Thr Lys Asn Thr Thr Phe Ala His Arg Glu Tyr Asp Val Ile Pro Asp Thr Lys Asn Thr
210 215 220 210 215 220
the
the
Leu Ile Pro Leu Asp Asp Met Val His Arg Ser Phe Phe Phe Gly Arg Leu Ile Pro Leu Asp Asp Met Val His Arg Ser Phe Phe Phe Gly Arg
225 230 235 240 225 230 235 240
the
the
Arg Glu Ile Ala Ala Leu Arg Arg Arg Val Pro His His Leu Arg Ser Arg Glu Ile Ala Ala Leu Arg Arg Arg Val Pro His His Leu Arg Ser
245 250 255 245 250 255
the
the
Ser Ser Thr Phe Glu Ile Leu Thr Ala Ser Leu Trp Lys Cys Arg Thr Ser Ser Thr Phe Glu Ile Leu Thr Ala Ser Leu Trp Lys Cys Arg Thr
260 265 270 260 265 270
the
the
Ser Ser Ile Gln Val Asp Pro Tyr Glu Glu Val Arg Ile Ile Cys Ile Ser Ser Ile Gln Val Asp Pro Tyr Glu Glu Val Arg Ile Ile Cys Ile
275 280 285 275 280 285
the
the
Val Asn Ser Arg Gly Lys Phe Asn Pro Pro Leu Pro Thr Gly Tyr Tyr Val Asn Ser Arg Gly Lys Phe Asn Pro Pro Leu Pro Thr Gly Tyr Tyr
290 295 300 290 295 300
the
the
Gly Asn Ala Leu Ala Leu Pro Val Ala Val Ala Glu Ala Gly Lys Val Gly Asn Ala Leu Ala Leu Pro Val Ala Val Ala Glu Ala Gly Lys Val
305 310 315 320 305 310 315 320
the
the
Ala Asn Asn Pro Leu Gly Tyr Ala Leu Glu Leu Val Lys Lys Ala Lys Ala Asn Asn Pro Leu Gly Tyr Ala Leu Glu Leu Val Lys Lys Ala Lys
325 330 335 325 330 335
the
the
Ala Glu Val Thr Glu Glu Tyr Met Lys Ser Val Ala Asp Leu Met Val Ala Glu Val Thr Glu Glu Tyr Met Lys Ser Val Ala Asp Leu Met Val
340 345 350 340 345 350
the
the
Ile Arg Gly Arg Pro His Phe Thr Ala Val Arg Thr Tyr Leu Val Ser Ile Arg Gly Arg Pro His Phe Thr Ala Val Arg Thr Tyr Leu Val Ser
355 360 365 355 360 365
the
the
Asp Leu Lys Arg Ala Gly Phe Arg Asp Val Asp Phe Gly Trp Gly Lys Asp Leu Lys Arg Ala Gly Phe Arg Asp Val Asp Phe Gly Trp Gly Lys
370 375 380 370 375 380
the
the
Ala Val Tyr Gly Gly Ala Ala Lys Gly Gly Val Gly Val Ile Pro Gly Ala Val Tyr Gly Gly Ala Ala Lys Gly Gly Val Gly Val Ile Pro Gly
385 390 395 400 385 390 395 400
the
the
Val Ile Ser Phe Phe Val Pro Phe Lys Asn Arg Asn Gly Glu Asp Gly Val Ile Ser Phe Phe Val Pro Phe Lys Asn Arg Asn Gly Glu Asp Gly
405 410 415 405 410 415
the
the
Ile Val Val Pro Val Cys Leu Pro Gly Pro Ala Met Glu Lys Phe Leu Ile Val Val Pro Val Cys Leu Pro Gly Pro Ala Met Glu Lys Phe Leu
420 425 430 420 425 430
the
the
Val Glu Ile Glu Arg Leu Thr Lys Val Ser Glu Met Glu Glu Glu His Val Glu Ile Glu Arg Leu Thr Lys Val Ser Glu Met Glu Glu Glu His
435 440 445 435 440 445
the
the
Gly Thr Asn Ala Gln Phe Ile Ala Ser Ala Leu Gly Thr Asn Ala Gln Phe Ile Ala Ser Ala Leu
450 455 450 455
the
the
<210> 4 <210> 4
<211> 31 <211> 31
<212> DNA <212> DNA
<213> 上游引物F1 <213> Upstream primer F1
the
the
<220> <220>
<221> misc_feature <221> misc_feature
<222> (29)..(29) <222> (29)..(29)
<223> n is a, c, g, or t <223> n is a, c, g, or t
the
<400> 4 <400> 4
tctccaaggc tctggtgttc taytayccnb t 31 tctccaaggc tctggtgttc taytayccnb t 31
the
the
<210> 5 <210> 5
<211> 32 <211> 32
<212> DNA <212> DNA
<213> 下游引物R1 <213> downstream primer R1
the
the
<220> <220>
<221> misc_feature <221> misc_feature
<222> (27)..(27) <222> (27)..(27)
<223> n is a, c, g, or t <223> n is a, c, g, or t
the
<220> <220>
<221> misc_feature <221> misc_feature
<222> (30)..(30) <222> (30)..(30)
<223> n is a, c, g, or t <223> n is a, c, g, or t
the
<400> 5 <400> 5
tgcatgaacc tgatagcgaa gryraanccn cc 32 tgcatgaacc tgatagcgaa gryraanccn cc 32
the
the
<210> 6 <210> 6
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 3′-RACE 1st Primer <213> 3′-RACE 1st Primer
the
<400> 6 <400> 6
gagttgctct tcgacgttga g 21 gagttgctct tcgacgttga g 21
the
the
<210> 7 <210> 7
<211> 24 <211> 24
<212> DNA <212> DNA
<213> 3′-RACE 2nd Primer <213> 3′-RACE 2nd Primer
the
<400> 7 <400> 7
cgctgatcct aattcaggtg actc 24 cgctgatcct aattcaggtg actc 24
the
the
<210> 8 <210> 8
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 5′-RACE 1st Primer <213> 5′-RACE 1st Primer
the
<400> 8 <400> 8
cgagccgaac attggcatca g 21 cgagccgaac attggcatca g 21
the
the
<210> 9 <210> 9
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 3′-RACE 2nd Primer <213> 3′-RACE 2nd Primer
the
<400> 9 <400> 9
tagaacacca gagccttgga 20 tagaacacca gagccttgga 20
the
the
<210> 10 <210> 10
<211> 23 <211> 23
<212> DNA <212> DNA
<213> Hctps1-P1 <213> Hctps1-P1
the
<400> 10 <400> 10
atggcatcat ccctcacttt ctc 23 atggcatcat ccctcacttt ctc 23
the
the
<210> 11 <210> 11
<211> 22 <211> 22
<212> DNA <212> DNA
<213> Hctps1-P2 <213> Hctps1-P2
the
<400> 11 <400> 11
ctagagggca gaagcaataa ac 22 ctagaggggca gaagcaataa ac 22
the
the
<210> 12 <210> 12
<211> 22 <211> 22
<212> DNA <212> DNA
<213> P1 <213> P1
the
<400> 12 <400> 12
attgtggtgc cagtttgctt gc 22 attgtggtgc cagtttgctt gc 22
the
the
<210> 13 <210> 13
<211> 24 <211> 24
<212> DNA <212> DNA
<213> P2 <213> P2
the
<400> 13 <400> 13
cccttttacc cttcgttgaa cttc 24 cccttttacc cttcgttgaa cttc 24
the
the
<210> 14 <210> 14
<211> 21 <211> 21
<212> DNA <212> DNA
<213> ACT-P1 <213> ACT-P1
the
<400> 14 <400> 14
ttcgtgttgc accagaagag c 21 ttcgtgttgc accagaagag c 21
the
the
<210> 15 <210> 15
<211> 22 <211> 22
<212> DNA <212> DNA
<213> ACT-P2 <213> ACT-P2
the
<400> 15 <400> 15
tgaatggcga catacatggc ag 22 tgaatggcga catacatggc ag 22
the
the
<210> 16 <210> 16
<211> 24 <211> 24
<212> DNA <212> DNA
<213> 上游引物F2 <213> Upstream primer F2
the
<400> 16 <400> 16
cttctacaca gccatcggtc caga 24 cttctacaca gccatcggtc caga 24
the
the
<210> 17 <210> 17
<211> 24 <211> 24
<212> DNA <212> DNA
<213> 下游引物R2 <213> downstream primer R2
the
<400> 17 <400> 17
gatgtaggag ggcgtggata tgtc 24 gatgtagggag ggcgtggata tgtc 24
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310369037.7A CN103436537B (en) | 2013-08-22 | 2013-08-22 | Lily ester floral gene LoAAT1 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310369037.7A CN103436537B (en) | 2013-08-22 | 2013-08-22 | Lily ester floral gene LoAAT1 and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103436537A CN103436537A (en) | 2013-12-11 |
CN103436537B true CN103436537B (en) | 2014-12-17 |
Family
ID=49690253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310369037.7A Expired - Fee Related CN103436537B (en) | 2013-08-22 | 2013-08-22 | Lily ester floral gene LoAAT1 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103436537B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107653234A (en) * | 2017-10-17 | 2018-02-02 | 华南农业大学 | A kind of ginger benzenoid form esters floral base is because of HcBSMT and its application |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107630025B (en) * | 2017-10-17 | 2020-04-14 | 华南农业大学 | A lily terpenoid floral aroma gene LoTPS3 and its application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102277362A (en) * | 2011-08-05 | 2011-12-14 | 华南农业大学 | Terpene fragrance gene Hctps1 from hedychium coronarium and use thereof |
-
2013
- 2013-08-22 CN CN201310369037.7A patent/CN103436537B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102277362A (en) * | 2011-08-05 | 2011-12-14 | 华南农业大学 | Terpene fragrance gene Hctps1 from hedychium coronarium and use thereof |
Non-Patent Citations (3)
Title |
---|
不同类型百合花瓣挥发性香气成分分析;范燕萍 等;《中国园艺学会观赏园艺专业委员会2008年学术年会》;20081231;418-421 * |
植物花香代谢调节与基因工程研究进展;赵印泉 等;《热带亚热带植物学报》;20111231;第19卷(第4期);381-390 * |
植物萜类合成酶及其代谢调控的研究进展;范燕萍 等;《园艺学报》;20111231;第38卷(第2期);379-388 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107653234A (en) * | 2017-10-17 | 2018-02-02 | 华南农业大学 | A kind of ginger benzenoid form esters floral base is because of HcBSMT and its application |
CN107653234B (en) * | 2017-10-17 | 2020-02-21 | 华南农业大学 | A kind of ginger flower benzene ring ester flower aroma gene HcBSMT and its application |
Also Published As
Publication number | Publication date |
---|---|
CN103436537A (en) | 2013-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111690662A (en) | Application of soybean bHLH transcription factor GmPIF1 gene in promotion of isoflavone synthesis | |
US20170247713A1 (en) | Trichome-specific transcription factor modulating terpene biosynthesis | |
CN102277362B (en) | Terpene fragrance gene Hctps1 from hedychium coronarium and use thereof | |
CN103436537B (en) | Lily ester floral gene LoAAT1 and application thereof | |
AU2003278632A1 (en) | Plant alpha farnesene synthase and polynucleotides encoding same | |
US9090903B2 (en) | β-ketoacyl ACP-synthase II (KASII) gene from Jessenia bataua | |
US8709811B2 (en) | Materials and methods for synthesis of a flavor and aroma volatile in plants | |
CN104797712B (en) | The method for improving cotton fiber length | |
KR102369344B1 (en) | Composition for modifying the ratio of unsaturated fatty acids in seeds and seeds prepared by the same | |
CN118184755B (en) | Photinia fraseri transcription factor SgWRKY gene and application thereof | |
CN116970053B (en) | Plant carotenoid synthesis-related protein DcAPRR2 and its encoding genes and applications | |
CN118028516B (en) | A screening marker for the red peel phenotype of longan | |
JP5833827B2 (en) | Genes that increase oil and fat productivity of plants and methods for using the same | |
WO2010049506A2 (en) | Polynucleotides encoding caryophyllene synthase and uses thereof | |
JP5686977B2 (en) | Genes that increase oil and fat productivity of plants and methods for using the same | |
CN107417778B (en) | Breeding method of disease-resistant transgenic TaOMT-A wheat and related biological materials and applications | |
CN116768991A (en) | Soybean tetraspanning domain protein GmTET270 related to the regulation of lipid metabolism and its encoding genes and applications | |
CN116640775A (en) | Longan DlMYB15 gene that can enhance the ability of MBW complex to regulate anthocyanin synthesis | |
JP2004506406A (en) | Allene oxide cyclase gene and its use in jasmonic acid production | |
CN114591927A (en) | The protein IbPRX17 related to the development of sweet potato strips and tendons and its encoding gene and application | |
CN118726468A (en) | Protein IbbHLH112 related to sweet potato root growth and development and its application | |
CA2700545C (en) | Novel genes involved in petroselinic acid biosynthesis and method for producing petroselinic acid | |
AU2009317573A1 (en) | Expression cassettes for seed-enhanced expression in plants | |
EP1705249A1 (en) | Method for producing plants with increased biomass | |
CN102453704A (en) | Plant Photooxidative Stress Resistance Gene CRTISO and Its Application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141217 |
|
CF01 | Termination of patent right due to non-payment of annual fee |